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ABSTRACT 
Stabilizing potential of polyclonal antibodies recognizing the labile region of 
pancreatic ribonuclease A (RNase A) has been investigated. The dodecapeptide 
SRNLTKDRAKPV corresponding to the labile region 32-43 of RNase A (Lpep) was 
synthesized by the solid-phase method. Antiserum raised against the Lpep-BSA 
conjugate in rabbits showed good cross-reactivity with the peptide and native RNase A. 
RNase A immobilized on Sepharose support precoupled either with the antiLpep IgG or 
antiRNase IgG proved to be more resistant to thermal inactivation than the soluble 
enzyme. Besides, stability of RNase A immobilized on the antiLpep IgG support against 
inactivation by trypsin at 55°C was markedly higher, as compared to that of the soluble 
enzyme and other immobilized preparations. The support bearing the antiLpep antibodies 
was superior in protecting the bound RNase A from inactivation both in the acidic and 
alkaline pH range as compared to the support bearing antiRNase antibodies. These results 
suggest that matrices precoupled with antibodies recognizing specific labile regions of 
enzyme may be useful in selectively improving the stability of the enzymes against 
specific forms of inactivation. 
The exchange of one amino acid residue (Leu35->Ser) in the unfolding region of 
RNase A is shown to have a dramatic destabilizing effect (ATm=9''C). Antibodies raised 
against the dodecapeptide corresponding to the labile region of RNase A were quite 
effective in stabilizing L35S-RNase against inactivation at 65°C for 2 h and surpassed the 
stabilization effect of antiRNase antibodies. Eleven percent contribution to the stabilizing 
effect of antiRNase antibodies was shown to result from antibodies recognizing the 
unfolding region of the enzyme. The results demonstrate the significance of the labile 
region of RNase A for the thermal stability of the molecule and potential of the strategy 
of stabilizing enzymes with the help of antibodies directed against labile structural 
regions. 
RNase A has been shown to aggregate moderately and gradually at 65°C. Antibodies 
raised against the dodecapeptide KETAAAKFERQG corresponding to the N-terminal 
region 1-12 on RNase A (Npep) as well as native RNase A were effective in lowering 
RNase A aggregation at 65°C. The antiRNase antibodies were however more protective. 
Reduction of RNase A aggregation by.antiNpep antibodies is likely to result from their 
interference in the minor dimer and later oligomer formation resulting from the binding 
of the antibodies to the N-terminal part of the enzyme. This may create steric hindrance in 
the swapping of the N-terminal a-helices of the monomers. The antiRNase antibodies 
were presumably more effective in protecting RNase A against aggregation, in view of 
their likelihood of recognizing several epitopes of the enzyme including the N-temiinal 
region and hence create steric hindrance in the approach of the monomers from all 
directions. 
A recombinant phospholipase D from white cabbage (PLD2) comprising of 812 amino 
acid residues was studied by site directed mutagenesis and limited proteolysis to identify 
weak/labile (flexible) region(s) of the enzyme. Limited proteolysis by thermolysin 
facilitated the seperation of few large fragments of PLD2. From mass spectrometry and 
N-terminal sequencing of the peptides, the cleavage sites could be identified as Thr41-
ne42, Asn323-Leu324 or Gly287-Leu288 and Ser319-Ile320 in case of the mutant 
L324S-PLD2. This suggested an exposed loop in the C2 domain of PLD2 and a large 
flexible region close to the N-tenninal side of the first catalytic (HKD) motif. Calcium 
ions, the substrate l,2-dipalmitoyl-.s'/7-glycero-3-phosphocholine and the competitive 
inhibitor l,3-dipalmitoylglycero-2-phosphocholine influenced the proteolytic cleavage. 
Calcium ions exerted a destabilizing effect on the conformation of PLD2. 
PLD2 immobilized covalently on CNBr-activated Sepharose expressed low activity 
(-10 %), while that immobilized non-covalently onto antiPLD2 IgG-Sepharose was more 
active (-38 %). Coupling of PLD2 to CNBr-activated Sepharose resulted in significant 
improvement in storage stability as well as in the retained activity upto SO'^ C, as 
compared to the soluble enzyme. Antibodies raised against the recombinant PLD2 were 
however not only ineffective in stabilizing the enzyme against high temperature and 
storage but actually rendered the enzyme labile against high temperature. 
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Jl Sstract 
ABSTRACT 
Stabilizing potential of polyclonal antibodies recognizing the labile region of 
pancreatic ribonuclease A (RNase A) has been investigated. The dodecapeptide 
SRNLTKDRAKPV corresponding to the labile region 32-43 of RNase A (Lpep) was 
synthesized by the solid-phase method. Antiserum raised against the Lpep-BSA 
conjugate in rabbits showed good cross-reactivity with the peptide and native RNase A. 
RNase A immobihzed on Sepharose support precoupled either with the antiLpep IgG or 
antiRNase IgG proved to be more resistant to thermal inactivation than the soluble 
enzyme. Besides, stability of RNase A immobilized on the antiLpep IgG support against 
inactivation by trypsin at 55°C was markedly higher, as compared to that of the soluble 
enzyme and other immobilized preparations. The support bearing the antiLpep antibodies 
was superior in protecting the bound RNase A from inactivation both in the acidic and 
alkaline pH range as compared to the support bearing antiRNase antibodies. These results 
suggest that matrices precoupled with antibodies recognizing specific labile regions of 
enzyme may be useful in selectively improving the stability of the enzymes against 
specific forms of inactivation. 
The exchange of one amino acid residue (Leu35—>Ser) in the unfolding region of 
RNase A is shown to have a dramatic destabilizing effect (ATni=9°C). Antibodies raised 
against the dodecapeptide corresponding to the labile region of RNase A were quite 
effective in stabilizing L35S-RNase against inactivation at 65°C for 2 h and surpassed the 
stabilization effect of antiRNase antibodies. Eleven percent contribution to the stabilizing 
effect of antiRNase antibodies was shown to result from antibodies recognizing the 
unfolding region of the enzyme. The results demonstrate the significance of the labile 
region of RNase A for the thermal stability of the molecule and potential of the strategy 
of stabilizing enzymes with the help of antibodies directed against labile structural 
regions. 
RNase A has been shown to aggregate moderately and gradually at 65°C. Antibodies 
raised against the dodecapeptide KETAAAKFERQG corresponding to the N-terminal 
region 1-12 on RNase A (Npep) as well as native RNase A were effective in lowering 
RNase A aggregation at 65°C. The antiRNase antibodies were however more protective. 
Reduction of RNase A aggregation by antiNpep antibodies is iilcely to result from their 
interference in the minor dimer and later oligomer formation resulting from the binding 
of the antibodies to the N-terminal part of the enzyme. This may create steric hindrance in 
the swapping of the N-terminal a-helices of the monomers. The antiRNase antibodies 
were presumably more effective in protecting RNase A against aggregation, in view of 
their likelihood of recognizing several epitopes of the enzyme including the N-terminal 
region and hence create steric hindrance in the approach of the monomers from all 
directions. 
A recombinant phospholipase D from white cabbage (PLD2) comprising of 812 amino 
acid residues was studied by site directed mutagenesis and limited proteolysis to identify 
weak/labile (flexible) region(s) of the enzyme. Limited proteolysis by thermolysin 
facilitated the seperation of few large fragments of PLD2. From mass spectrometry and 
N-terminal sequencing of the peptides, the cleavage sites could be identified as Thr41-
lle42, Asn323-Leu324 or Gly287-Leu288 and Ser319-Ile320 in case of the mutant 
L324S-PLD2. This suggested an exposed loop in the C2 domain of PLD2 and a large 
flexible region close to the N-terminal side of the first catalytic (HKD) motif Calcium 
ions, the substrate l,2-dipalmitoyl-.s'«-glycero-3-phosphocholine and the competitive 
inhibitor l,3-dipalmitoylglycero-2-phosphocholine influenced the proteolytic cleavage. 
Calcium ions exerted a destabilizing effect on the conformation of PLD2. 
PLD2 immobilized covalently on CNBr-activated Sepharose expressed low activity 
(-10 %), while that immobilized non-covalently onto antiPLD2 IgG-Sepharose was more 
active (-38 %). Coupling of PLD2 to CNBr-activated Sepharose resulted in significant 
improvement in storage stability as well as in the retained activity upto 50°C, as 
compared to the soluble enzyme. Antibodies raised against the recombinant PLD2 were 
however not only ineffective in stabilizing the enzyme against high temperature and 
storage but actually rendered the enzyme labile against high temperature. 
List of Abbreviations 
a.a. 
BSA 
DAB 
DTT 
EDTA 
ELISA 
HRP 
IgG 
Lpep 
MALDI-TOF 
Npep 
PBS 
1,2-PC 
1,3-PC 
PLD2 
PMSF 
PpNP 
PVDF 
RNase A 
RSA 
SDS 
SDS-PAGE 
Amino acid residue 
Bovine serum albumin 
Diaminobenzidine 
Dithiothreitol 
Ethylenediaminetetraacetic acid 
Enzyme linked immunosorbent assay 
Horseradish peroxidase 
Immunoglobulin G 
Dodecapeptide corresponding to the labile region of RNase A 
(32-43) 
Matrix-assisted laser desorption/ionization-time of flight 
Dodecapeptide corresponding to the N-terminal region of 
RNase A (1-12) 
Phosphate buffered saline 
l,2-dipalmitoyl-5n-glycero-3-phosphocholine 
l,3-dipalmitoylglycero-2-phosphocholine 
Recombinant phospholipase D2 from cabbage expressed in 
E. coli 
Phenylmethanesulphonylflouride 
Phosphatidyl-p-nitrophenol 
Polyvinylidene difluoride 
Pancreatic ribonuclease A 
Rabbit serum albumin 
Sodium dodecylsulphate 
SDS-Polyacrylamide gel electrophoresis 
LIST OF FIGURES 
Page No. 
1. Ribbon diagram of the three-dimensional structure of RNase A. 2 
2. Putative mechanism for the reactions catalyzed by RNase A. 4 
3. Hydrolysis ofphosphatidylcholine by PLD, PLC, PLA2,PLAi,PLB, 16 
and lysoPLA and the respective reaction products. 
4. Stereographic illustration of PLD from Streptomyces sp. strain PMF. 19 
5. Amino acid sequence of PLD2 from cabbage. 24 
6. Models of the unfolding region. 28 
7. SDS-PAGE and MonoS-FPLC column chromatography of 50 
commercial RNase A. 
8. Effect of time of incubation, enzyme concentration, temperature and 51 
pH on the hydrolysis of RNA. 
9. Detection of the antiRNase antibodies in the antiserum. 52 
10. Elution profile of antiRNase A IgG from a Protein A-Sepharose 53 
column. 
11. SDS-PAGE of IgG and determination of molecular weight of the 54 
IgG. 
12. Western blot analysis and ELISA of antiLpep-BSA antiserum. 56 
13. Cross-reactivity of the RNase A specific antibodies with the Lpep. 57 
14. ELISA showing the cross-reactivity of antiNpep-BSA antiserum 58 
with the Npep or RNase A. 
15. Effect of temperature on the activity of soluble and immobilized 61 
RNase A. 
16. Effect of pH on the activity of soluble and immobilized RNase A. 62 
17. Effect of trypsin on soluble and immobilized RNase A. 63 
IV 
18. Tertiary structure of RNase A, 65 
19. Effect of temperature treatment on the activity of RNase A and 67 
L35S-RNase A. 
20. Themial transition of RNase A and L35S-RNase A at pH 5.0. 68 
21. Detection of RNase A and L35S-RNase A aggregation by SDS- 70 
PAGE. 
22. Thermal inactivation of soluble and immobilized L35S-RNase A 71 
preparations at 65°C. 
23. Aggregation of RNase A at 65°C. 72 
24A. Lack of adhesion of RNase A on the eppendorf tubes. 73 
24B. Aggregation of RNase A in presence of antibodies at 65°C. 73 
25A. Purification of PLD2 expressed in E. coli BL21 (DE3) cells using 75 
octyl-Sepharose. 
25B. Purification of PLD2 expressed in E. coli BL21 (DE3) cells using 75 
MonoQ. 
26. Proteolysis of PLD2 by chymotrypsin and trypsin at 25°C. 76 
27. Proteolysis of PLD2 by thermolysin at 25°C. 77 
28. Blot of PLD2 and its fragments formed after proteolysis by 81 
thermolysin. 
29. Proteolysis of PLD2 by thermolysin at 25°C after preincubation at 83 
various temperatures. 
30. Proteolysis of PLD2 by thermolysin at 25°C in the absence and in 84 
the presence of 20 mM CaCl2. 
31. Effect of 1,2-PC and 1,3-PC on proteolysis of PLD2 by 86 
thermolysin in the presence and absence of CaCh. 
32. Purification of I42S-PLD2 expressed in E. coli BL21 (DE3) cells. 87 
33. Proteolysis ofL324S-PLD2 by themiolysin at 25°C. 89 
34. Western blot showing the cross-reactivity of antiPLD2 antibodies 90 
V 
with PLD2. 
35. Purification of antiPLD2 IgG on Protein A-Sepharose column. 91 
36. Stability of soluble and immobilized PLD2. 94 
37. Effect of temperature on the activity of soluble and immobilized 95 
PLD2. 
38. Storage stability of soluble and immobilized PLD2. 96 
39. Thermolysin cleavage sites on PLD2. 104 
VI 
LIST OF TABLES 
Page No. 
1. Comparison of the amino acid sequence of the recombinant PLD2 22 
from cabbage with other plant, animal and microbial PLDs. 
2. Enzyme immobilized favourably with the help of antibodies. 26 
3. ImmobilizationofRNase AonCNBr activated and antibody coupled 59 
Sepharose supports. 
4. Specific activity and Tm of RNase A and L35S-RNase A. 66 
5. Tryptic peptides of PLD2 and its fragments formed after 79 
proteolysis by thermolysin as determined by MALDI-TOF mass 
spectrometry. 
6. N-terminal sequences of the fragments of PLD2 and L324S-PLD2 82 
obtained by proteolysis with thermolysin. 
1. ImmobilizationofPLD2 on CNBr activated, and antiPLD2 92 
IgG-Sepharose supports. 
VII 
Introduction 
1. INTRODUCTION 
1.1. Ribonuclease A 
The hydrolysis of RNA in vivo is catalyzed by RNA depolymerases, which are most 
often described as "ribonucleases". The high level of ribonucleolytic activity in the 
pancrease of ruminants has led to the discovery (Jones, 1920) and detailed characterization 
of bovine pancreatic ribonuclease A (RNase A) (EC 3.1.27.5). RNase A has been used 
extensively as a model protein in view of its small size, well understood three dimensional 
structure and readily reversible denaturation behaviour. 
1.1.1. Structure 
The crystallization of RNase A dates back to more than 60 years (Kunitz, 1939; Kunitz, 
1940) and these crystals were shown to diffract to a resolution of 2 A (Fankuchen, 1941). 
RNase A is the first enzyme and third protein to be sequenced (Hirs et al, I960; Smyth et 
al, 1963). It is also the first protein shown to contain an isoaspartyl residue, derived from 
the deamidation of an asparagine residue (Asn67) (Capasso, 1996). 
RNase A is a small protein, consisting of 124 amino acid residues and with a molecular 
mass of 13,690 daltons (Pace et al, 1995). It contains all the natural amino acids except 
tryptophan. The number of tyrosines in the enzyme is six and the protein is cross-linked by 
four disulphides (26-84, 40-95, 58-110, 65-72); there are no free cysteines in the enzyme. 
RNase A has four proline residues located at positions 42, 93, 114, and 117. The peptide 
bonds preceding two of the four proline residues are in the cis conformation and are in 
type VI reverse turns at opposite ends of the native enzyme (Chou & Fasman, 1977). The 
secondary structure consists of long four-stranded antiparallel p-sheets and three short a-
helices. The overall shape of the enzyme resembles that of a kidney, with the active-site 
residues lying in the cleft (fig. 1). 
1.1.2. Catalysis 
RNase A acts on the phosphodiester bond located between the 5 '-ribose of a nucleotide 
and the phosphate group attached to the 3'-ribose of an adjacent pyrimidine nucleotide, 
N i 
N 
Fig. 1. Ribbon diagram of the three-dimensional structure of ribonuclease A. The 
model was taken from the Brookhaven protein data bank and drawn with RASMOL. 
forming a 2', 3'-cyclic phosphate, which is then hydrolyzed to the corresponding 3'-
nucleoside phosphate (fig. 2). The action of the enzyme on ribonucleic acid or pyrimidine 
nucleotide 3 '-esters therefore involves two successive reactions; the formation of cyclic 
phosphates and subsequent hydrolysis of the cyclic esters to give the 3'-nucleotides. Poly 
(C) is cleaved by pancreatic RNase A approximately 20-fold faster than is poly (U) 
(delCardayre & Raines, 1994). Early work on the study of kinetics of catalysis by RNase 
A used RNA (Kunitz, 1946) or nucleoside 2', 3'-cyclic phosphodiesters (Crook, 1960) as 
substrates. Homopolymeric substrates such as poly (U) and poly (C) are now readily 
available. Uridylyl (3'-»5') adenosines, which have well-defmed extinction coefficients 
(Warshaw & Tinoco, 1966) have become the most often used oligonucleotide substrates. 
A new fluorogenic substrate provides the basis for an extremely sensitive assay for RNase 
A. 5'[-0-[4-[(2,4-Dinitrophenyl)amino]butyl]phosphoryl]uridylyl(3'->'5')2'-deoxyadenosine3'-[N-
[(2-aminobenzoyl)-amino] prop-3-yl] phosphate enables the detection of a 50 fM 
concentration of RNase A (Zelenko et al, 1994). 
The most potent proteinic RNase A inhibitor among these is the mammalian 
ribonuclease inhibitor (RI) (Blackburn & Moore, 1982), while 5'-diphosphoadenosine 3'-
phosphate and 5'-diphosphoadenosine 2'-phosphate are the most potent small molecular 
weight inhibitors (Russo et al., 1997). 
1.1.3. Folding and stability 
RNase A has remarkable stability against inactivation compared to enzymes from 
mesophilic sources. It maintains its molecular integrity even under drastic conditions i.e at 
95-100°C at pH 3.0 and in 0.25 N sulphuric acid at 5°C (Kunitz & McDonald, 1953). Its 
amino acid sequence fully encodes its three dimensional structure (Anfmsen et al., 1961), 
hence it has been used extensively as a model protein for eluciding the principles of 
protein folding. 
The four disulphide bonds in RNase A are critical to the stability of the native enzyme. 
The enzyme unfolds upon reduction of its disulphide bonds, even in the absence of 
denaturants, which indicates that folding is coupled to disulphide bond formation. 
Extensive studies on the theiTnodynamic stability, structure, and folding/unfolding kinetics 
of wild-type RNase A suggest that RNase A folds through multiple pathways (Rothwarf & 
;'RNA. 
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"0-
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Fig. 2. Putative mechanism for the transphosphorjlation reaction (a) and for the 
hydrolysis reaction (b) catalyzed by RNase A. In both mechanisms, B is Hisl2 and A 
is HisI 19. (Raines, 1998). 
Scheraga, 1993; Li et ai, 1995). Replacing any cystine with another pair of amino acids 
reduces the thermal stability of the enzyme (Shimotakahara et ai, 1997). Specifically, two 
three-disulphide intermediates, des-[40-95] and des-[65-72] RNase A lacking the 40-95 
and 65-72 disulphide bonds, respectively, were observed during the oxidative regeneration 
or reductive unfolding of RNase A (Li et ai, 1995). The two disulphide bonds (Cys26-
Cys84 and Cys58-Cysl 10) contribute more to the thermal stability than do the other two 
(Cys40-Cys95 and Cys65-Cys72). 
RNase A exhibits a slow kinetic phase in its refolding (Tseng & Baldwin, 1972) which 
can be represented by the following equation: 
slow fast 
Us-^ • U f • N 
where N is the native enzyme, Uf are fast refolding species and Us are slow refolding 
species. In RNase A, Pro42 and Proll7 are trans and Pro93 and Pro 114 are cis. The 
isomerization of one or both of the cis peptide bonds may be responsible for the slow 
kinetic phase observed during the refolding of RNase A. Pro93 peptide bond is trans in the 
slowest refolding species (Dodge & Scheraga, 1996) and hence trans-to-cis isomerization 
of that bond is the slowest step in the refolding of the fully denatured enzyme. 
RNase A loses almost complete activity in 2-3 M guanidine, without undergoing major 
conformational changes (Liu & Tsou, 1987). At concentrations above 4.5 M GdnHCl, the 
a-helical secondary structure breakdown occurs before the entire tertiary structure of the 
protein dissolves (Juneja & Udgaonkar, 2002). The rate-limiting step for the unfolding of 
RNase A is the dissolution of the entire native tertiary structure and penetration of water 
into the hydrophobic core. In the presence of 8 M urea, RNase A is completely inactive 
(Resnick et al., 1959). The thermal stability of RNase A decreases with increasing 
concentration of urea and the size of hydrophobic group substituted on the urea molecule 
(Poklar et al., 1999). In trifluoroethanol (TFE) concentration greater than 30 %, there is a 
cooperative collapse of the tertiary structure of RNase A coinciding with the loss of its 
activity (Koditz et ai, 2002). The breakdown of the tertiary structure in TFE is 
accompanied by the induction of secondary structure. 
The solution stability of RNase A in phosphate buffer (pH 4.0, 6.4, and 10.0) at 45°C 
decreases with increasing pH due to the formation of soluble aggregates (Townsend & 
Deluca, 1990). hi a later study, it was shown by concurrent static light scattering that 
RNase A aggregation was observed at dS^C and above when much of the protein was 
denatured (Tsai et al, 1998a). In contrast, heat denaturation did not lead to RNase A 
aggregation in a very acidic medium due to the effect of charge-charge repulsion between 
the highly protonated RNase A molecules. At 75°C, SDS and dextran sulphate were 
successful in preventing RNase A aggregation, whereas their cationic, nonionic, 
zwitterionic analogs were not (Tsai et al, 1998b). When concentrated in mildly acidic 
solutions, RNase A fomis long-lived oligomers (Liu et al, 2002). The major dimeric 
component forms by a swapping of the C-terminal (3-strands between the monomers, and 
the minor dimeric component forms by swapping the N-terminal a-helices of the 
monomers. RNase A can form both a linear and a cyclic domain-swapped oligomer. 
1.1.4. Thermal Unfolding 
The reversible thermal denaturation of RNase A proceeds in a manner consistent with a 
stepwise unfolding mechanism rather than as a transition between the two states. The 
unfolding process has been studied by static temperature methods (Chen & Lord, 1976; 
Lustig & Fink, 1992; Fink & Fainter, 1987), fluorescence (Houry et al, 1994), X-ray 
scattering and fourier transform IR (Sosnick & Trewhella, 1992; Seshadri et al, 1994), 
NMR (Udgaonkar & Baldwin, 1988; Mayo & Baldwin, 1993; Akasaka et al, 1991; 
Udgaonkar & Baldwin, 1990) and CD (Scholtz & Baldwin, 1993) Spectroscopy. During 
thermal denaturation, the native protein first relaxes towards an unfolded intermediate 
state, which then slowly equilibrates with more fully denatured structures. The fast 
unfolding step(s) involves the dismantling of the protein secondary structure, whereas the 
slower ones have been attributed to specific isomerization involving the proline residues 
(Juminaga et al, 1997). 
The unfolding of RNase A at pH 5.0 in 0.1 M NaCl over the temperature range 
32-70°C as studied by Raman Spectroscopy shows that the unfolding begins at 55°C, the 
melting temperature is at or near 62°C and substantial helical and pleated-sheet 
conformations remain even at 70°C (Chen & Lord, 1976). Thermal denaturation as 
followed by ultraviolet absorbance at pH 8.0 at 287 nm reveals that the unfolding becomes 
significant above 47.5°C and the transition temperature was 62.5°C (Arnold et ai, 1996). 
The transition temperature (Ttr) increases from pH 0.5 to pH 6.0, but appears to be 
independent of pH below pH 0.5 and above pH 6.0 (Hermans & Scheraga, 1961). The 
thermally denatured form of RNase A has been shown to be not completely unfolded with 
retention of nonrandom structure (Seshadri et ai, 1994; Privalov et ai, 1989; Tamura & 
Gekko, 1995). RNase A denatured by heat can therefore be further unfolded by treatment 
with guanidine chloride (Robertson & Baldwin, 1991). During the thermal unfolding of 
RNase A at neutral or acid pH, evidence of the appearance of intemiediates were found 
with the help of calorimetry (Tsong et ai, 1970), spectroscopy (Chen & Lord, 1976), 
NMR and CD measurements (Adler & Scheraga, 1988). 
The irreversible thermoinactivation of RNase A at 90°C and pH 4.0 is caused by 
hydrolysis of peptide bonds at aspartic acid residues (the main process) and deamidation 
of asparagine and/or glutamine residues (Zale & Klibanov, 1986). However, at 90°C and 
neutral pH (pH 6.0 and 8.0), the enzyme inactivation is caused by a combination of 
disulphide interchange (the main process), P-elimination of cystine residues, and 
deamidation of asparagine and/or glutamine residues. 
1.1.5. Proteolytic susceptibility 
Subtilisin cleaves a single bond in native RNase A (Richards, 1955; Rupley et al., 
1962) resulting in the formation of RNase S comprising of two tightly associated 
fragments. These fragments are designated as S-peptide derived from residues 1-20 of 
RNase A and S-protein from residues 21-124. Although neither fragment alone has any 
ribonucleolytic activity, RNase S has enzymatic activity similar to that of intact RNase A. 
The proteolytic susceptibility of RNase A towards the proteases subtilisin, elastase and 
proteinase K was comparable (Arnold et al., 1996) and the enzyme was fragmented even 
at 20°C. Therefore, these proteases were not suitable for investigating thermal unfolding 
by proteolysis. However, when Ala20 was substituted for Pro by site directed mutagenesis, 
the resulting mutant enzyme was nearly identical to the wildtype enzyme in the near-UV 
and far-UV CD spectral properties, in its activity towards 2', 3'-cCMP and in its 
thermodynamic stability, but the proteolytic resistance to proteinase K and subtilisin 
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carlsberg was remarkably increased (Markert et ai, 2001). Subtilisin treated RNase A has 
been useful in conformational studies. Complete reduction, followed by reoxidation of S-
protein resulted in significant regain of enzyme activity when the material was assayed in 
the presence of the S-peptide. This finding suggested that "infonnation" determining the 
formation of secondary and tertiary structure of RMase A is present in the amino acid 
sequence of S-protein (Holmes & Yarwood, 1989). Although limited covalent changes 
may not markedly disrupt the apparent conformation of RNase A in aqueous solution at 
room temperature, they may be responsible for a marked decline in the conformational 
stability of the derivatives, readily apparent on denaturation by heat and urea. Studies on 
the combined effects of heat and urea on the relative conformational stability of RNase A, 
RNase S and S-protein, showed that RNase A was the most resistant to unfolding, while S-
protein was the most labile (Hubbard et al, 1994). The difference in thermal stability 
between RNase S and RNase A were attributed to entropic effects, i.e a greater 
conformational flexibility of both backbone and side chains in RNase S (Lang et al, 
1986). 
Ficin, an endopeptidase of plant origin, cannot cleave native RNase A but can act on 
the thermally denatured enzyme (Winchester et al, 1970). There is no loss of 
ribonucleatic activity when RNase A is incubated with ficin at 25°C and pH 4.2. However, 
on performing the digestion at 6(fC and pH 4.2, conditions under which RNase A is 
known to undergo a reversible thermal transition, virtually all enzyme activity was lost 
within 10 min. Digestion by ficin results in the formation of transient intermediates 
possessing enzyme activity. The existence of such intermediates confirms that some of the 
initial points of proteolysis are not associated with the active site (Winchester et al, 1970). 
Chymotrypsin also does not hydrolyze native RNase A at an appreciable rate 
(Spackman, et al, 1960) but rapidly cleaves the thermally unfolded enzyme (Rupley et al, 
1962). Amino acid analyses of the intennediates found in chymotrypsin digests of 
thennally unfolded RNase A shows that the sites of chymotryptic attack are Tyr25-Cys26, 
Leu35-Thr36, Phe46-Val47, Tyr76-Ser77, Met79-Ser80, Tyr97-Lys98 and an unidentified 
bond whose N-terminal member is Glu or Gin (Rupley & Scheraga, 1963). Therefore, 
three regions of the molecule were identified that unfold and these are; around residues 73 
to 80, around half-cystine 26, and around tyrosine 97. The C-terminal region of RNase A 
including tyrosine 115 seem to be unaffected by the thermal unfolding, hi order to identify 
the region of RNase A that unfolds first during thermal unfolding. Arnold et al. (1996) 
tried to use chymotrypsin but all attempts to isolate large fragments reflecting the first 
cleavage site were unsuccessful. Therefore, chymotrypsin proved to be unsuitable for the 
localization of the region becoming first accessible to proteolysis during thennal 
unfolding. 
Trypsin cleaves the peptide bonds in which carbonyl group is contributed by Arg or 
Lys (Holmes & Yarwood, 1989). There are 14 potential trypsin cleavage sites in RNase A 
molecule (Lysl, Lys7, ArglO, Lys31, Arg33, Lys37, Arg39, Lys4L Lys61, Lys66, Arg85. 
Lys91, Lys98, Lysl04). However, it is essential that the local unfolding of at least 12 
residues around the cleavage site of a protein should have occured before getting cleaved 
by trypsin (Bums & Schachman, 1982). Native RNase A is also resistant against cleavage 
by trypsin at room temperature (Arnold et al, 1996; Ooi el al, 1963; Lang et al, 1986). 
Cleavage of RNase A by trypsin at 60°C occurs at Lys31-Ser32 and at Arg33-Asp34. 
Therefore, one of the region of RNase A which unfolds in the thermal transifion includes 
the region of the chain between Lys31 and Asp34, which is not an essential part of the 
active centre since activity remains in the cleaved molecule (Ooi et al, 1963). As has been 
already mentioned that in chymotryptic attack one of the cleavage site was Tyr25-Cys26 
and in tryptic attack there are two cleavage sites in the region from Lys31 to Asp34. This 
suggests that the region between residues 25-35 unfold during the thermal transition. The 
N-terminal tail from Lysl to Tyr25 has two positions which are cleaved by trypsin in 
RNase A (Hirs, 1956), viz., Lys7-Phe8 and ArglO-Glul L But these bonds are not cleaved 
in the early stages of digestion of RNase A at 60''C (Ooi et al, 1963), therefore, the N-
temiinal region seems not to unfold during the thermal transition. RNase A unfolding has 
also been studied by denaturation with guanidinium chloride (Yang & Tsou, 1995). After 
5 hrs of digestion in 1 M guanidinium chloride, trypsin cleaves at Arg33-Arg34 as 
observed in thermal denaturation experiments, and additionally at Argl 0-Glul 1. 
Lang et al (1986) applied trypsin pulses after varying durations of refolding of the 
polypeptide chain of RNase A. The sites of cleavage which become inaccessible in the 
course of refolding are located in the 31-39 chain segment of the RNase A chain. 
Protection of this region against attack by trypsin is achieved on the major slow refolding 
pathway in parallel with the formation of a native-like folded, active intemiediate, when 
refolding is carried out under conditions which strongly stabilize the folded state. The 
31-39 region of the RNase A chain is accessible at early stages of refoldir" ^^  •<= 
structured and hence does not become inaccessible until the fomiation of the overall 
folded native or native-like structure. This suggests that the 31-39 region of the RNase A 
chain is not important for early steps which direct the pathway of refolding. The major 
part of the 31-39 region in the native RNase A forms a solvent-exposed loop structure 
with a high degree of flexibility, as indicated by increased temperature factors of this 
segment of the chain (Wlodawer et al, 1982; Wlodawer & Sjolin, 1983). This region also 
shows a strong variability in the amino acid sequence in homologous RNases (Blackburn 
& Moore, 1982) and the trypsin-cleavage sites located there are among the first proteol>lic 
sites which become accessible upon entering the thermal transition of RNase A (Arnold et 
al, 1996; Ooi et al, 1963; Bums & Schachman, 1982; Ooi & Scheraga, 1964). In 
similarly folded S-protein (des-(l-20)-RNase), Lys31-Ser32 and Arg33-Asn34 are 
probably the first bonds to be split by trypsin (AUende & Richards, 1962). Taken together 
this evidence suggests that the 31-39 region of RNase A is not of central importance for 
the stability of the folded state. 
Thermolysin appears to be the most appropriate protease for studying the thermal 
unfolding of RNase A as it degrades only the unfolded enzyme molecules (Arnold et al. 
1996). Furthermore, thermolysin is adequately thermoresistent enough to withstand 
temperatures at which RNase A is denatured. Thermolysin attacks native RNase A at 50°C 
or higher temperatures (Arnold et al, 1996). The first two cleavage sites were found to be 
Asn34-Leu35 and Thr45-Phe46. 
A number of recent studies have focussed on the limited proteolysis of proteins in the 
presence of trifluroethanol (TFE) which is known to favour the fomiation of a-helix and 
facilitates the adoption of a partially folded state. Thermolysin has usually been used due 
to its high stability in TFE. When RNase A is incubated in 50 % TFE, thermolysin 
primarily cuts at Asn34-Leu35 although the native protein is completely resistant to 
proteolysis (Polverino De Laureto et al, 1997). Since the first cleavage sites are Lys31-
Ser32 and Arg33-Asn34 for trypsin as stated earlier and for thermolysin these are Asn34-
Leu35 and Thr45-Phe46, the region from Lys31 to Leu35, together with the adjacent (3-
structure containing Thr45-Phe46 is suggested to represent a labile region of the RNase A 
molecule (Arnold et al, 1996). Proteolysis is a useful method for the determination of 
unfolding constants. Thermolysin which possesses at least 32 potential cleavage sites in 
RNase A molecule is unspecific and stable enough to be suitable for the detemiination of 
unfolding constant of RNase A. The unfolding constant determined by Imoto et al (1986) 
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for RNase A at 50"C and pH 8.0 is (10.1 ± 0.4) xlO"* S"' by themiolysin. This is 
comparable with the value ( 9.19 ± 0.54) x 10""* S"' determined by Arnold et al. (1996). 
The analysis of the proteolytic studies suggests that the different regions of RNase A 
have varying levels of stability (Hubbard, 1998). The mobile loop around residue 20 is 
readily cleaved by several proteinases, even at 20°C. At slightly higher temperature this 
region is extended out towards residue 25 susceptible to chymotrypsin cleavage. At still 
higher temperature, the end of the helix from Asn24-Asn34 may partly unfold to allow 
cleavage by trypsin at this region, and also destabilize the following P-strand to permit 
hydrolysis by themiolysin at residue 45. The region from Lys31 to Leu35, along with the 
adjuscent P-structure containing Thr45-Phe46 is suggested to represent a thermolabile 
region of RNase A which is not of central importance to the stability of the molecule. 
/. i. 6. Roles of constituent amino acid residues 
Bovine pancreatic RNase A has 124 constituent amino acid residues. The structural and 
functional roles of various amino acid residue of RNase A have been analyzed by several 
strategies, which include chemical modification in combination with chemical synthesis 
using the S-peptide/S-protein system (Chatani & Hayashi, 2001). However, these 
methodologies have mainly addressed the polar amino acid residues. More recently, an 
efficient expression system for RNase A using E. coll has been developed (delCardayre et 
al., 1995), that facilitated the generation of mutant enzymes with altered polar/nonpolar 
amino acid residues on a large scale. 
The amino acids (His 12, Lys41, Hisl 19, Gin 11, Phel20 and Aspl21) have been shown 
to participate directly in RNase A action (Raines, 1998). Hisl2, Hisl 19 and Lys41 have 
been shown to constitute the active site of RNase A. Chemical modification of His 12, 
Hisl 19 (Crestfield et al., 1963) or Lys41 (Heinrikson, 1966) results in the loss of most of 
RNase A activity. Recombinant DNA techniques further revealed that His 12 and Hisl 19 
act as an acid and a base and that Lys41 stabilizes the transition state (Richards & 
Wyckoff, 1971; Thompson & Raines, 1994). Hisl 19 also participates directly in transition 
state stabilization via hydrogen bonding (Panov et al, 1996). Crystallographic 
investigation of the complex of RNase A with substrate analogues (Richards & Wyckoff, 
1971; Fontecilla-Camps et al., 1994; McPherson et al., 1986) and a series of site-directed 
mutagenesis studies, revealed six substrate binding subsites, P.i, Po, Pi, P2, Bi, B2, and B3. 
The amino acid residues associated with the sites include Arg85 at P.i (Fisher et al., 
1998a), Lys66 at Po, Glnll, Phel20, and Aspl21 at Pj, Lys7 and Argf " Thr45, 
Asp83, and Phel20 at B|, Asn71 and Glulll at B2 with their respective ionic clusters 
(Raines, 1998). 
The indirect role of Lys7, ArglO, and Lys66 in the catalytic reaction of RNase A has 
been elucidated by the mutation of these residues, which not only significantly affect the 
Km but also the K^ at of the enzyme (Boix et al., 1994; Fisher e/ ai, 1998b). The 
replacement of Aspl21 with Asn in a semisynthetic RNase A reduces the catalytic 
efficiency (Stem & Doscher, 1984), while the mutagenic replacement of Phel20 by other 
amino acid residues alters both catalytic efficiency and thermal stability (Tanimizu et ai, 
1998; Chatani et al., 2001). Replacement of Tyr97 with Phe, Ala or Gly also leads to a 
decrease in acfivity since Tyr97 is involved in maintaining the correct position of Lys41 
(Eberhardt et al., 1996). The replacement of the cysteine residues of the disulphide Cys26-
Cys84 or Cys58-Cysll0 with alanine decreases the thermal stability by 40°C without 
affecting Kca/K^ for Poly (C), but the removal of Cys40-Cys95 or Cys65-Cys72 
drastically decreases the Kca/Km rather than conformational stability (Klink et al., 2000). 
Some synthetic [Oml0]-S-peptide analogues, containing Phe, Tyr, He, Ala, cpGly, and 
Gly at position 8 showed that Phe8 plays an important role in a-he!ix stability, and that the 
capability of these peptides to bind to the S-protein is in the order of 
Phe>Tyr>cpGly>lle>(Gly, Ala) at position 8. This result reveals the significance of 
hydrophobic interactions of S-peptide with the S-protein (Filippi et al., 1976). A study of 
P42A, P93A, P114A, and P117A showed that the isomerizafion of the Tyr92-Pro93, 
Asnl 13-Prol 14, and Vail 16-Prol 17 pepdde bonds effects the folding process (Dodge & 
Scheraga, 1996). The replacement Pro93 with glycine has an effect not only on folding 
rate, but also on the thermal stability (Schultz et al., 1998). From a study of Y25F and 
Y97F mutant RNase A, it has been shown that Tyr25 and Tyr97 contribute to accelerating 
conformafional refolding and the confoiTnafional stability as well as the cis-trans 
isomerization of the slow-refolding phases (Juminaga et ai, 1997). 
The importance of the C-terminal region in constituting the active site has been 
suggested by the fact that des [121-124] RNase A, a mutant enzyme lacking the 121-124 
C-terminal residues, possesses only about 0.5 % of the activity of the nafive enzyme 
towards cytidine-2,3-cyclic monophosphate (Lin, 1970). The replacement of the C-
terminal Vail24 residue with other amino acids, such as Gly, Ala, Lys or Trp decreases 
the recovery of activity in refolding from S-S reduced form, implying that the C-terminal 
amino acid residue significantly affects the fonnation of the correct disulphide bonds 
'jring the refolding process, and that the hydrophobic interaction of Vail24 is impc 
for efficient packing of RNase A molecule (Fujii et al., 2000). An NMR study of the 
(C65S, C72S) mutant RNase A, lacking the Cys65-Cys72 disulphide bond, has indicated 
that some interactions exist between the 65-72 disulphide loop and the C-temiinus. 
Moreover, the hydrogen-bonding network within the hydrophobic core is destroyed, 
suggesting that this disulphide bond also contributes significantly to stabilizing the 
hydrophobic core of the native protein (Shimotakahara et al., 1997). 
Immunological reactivity analysis suggests that some ordered structures exist for the S-
S reduced form of RNase A (Chavez & Scheraga, 1977; Chavez & Scheraga, 1979; 
Chavez & Scheraga, 1980). These structures are refered to "chain folding initiation sites 
(CFIS)". The peptide fragments of 1-13 (Rico et al., 1986), 21-42 (Jimenez et al., 1988) 
and 50-61 (Jimenez et al., 1987) can fold to native-like a-helices, while the 80-124 
(Chavez & Scheraga, 1977) and 105 (or 109)-124 (Beals et a/., 1991) fragments also have 
partially ordered structures, suggesting that the CFIS can form the ordered structures with 
relatively short-range interactions. The residues from 106 to 118 have been shown to 
stabilize the conformation of RNase A (Torrent, 2001). The refolding of Y92W by double-
jump refolding experiments revealed a hydrophobically-coUapsed intermediate, which 
supports the hypothesis that the region around position 92 is also a CFIS in the folding 
pathway (Sendak et al., 1996). 
The mutagenic replacement of Phe46 with Glu or Lys changes a part of the (3-sheet to 
random coils. Moreover, the replacement of Phe46 with Val folds to the native structure 
with full activity, but the replacement with Ala loses the ability to fold to the native 
structure. These results and a comparison between temperature and pressure denaturation 
(Chatani et al., 2002) suggests that the hydrophobicity of the side chain of Phe46 is crucial 
to the formation of the correct secondary and tertiary structures in protein folding. 
Onconase is a highly cytotoxic homolog of RNase A (Mikulski et al., 1995). RNase A 
can also be made toxic to cancer cells by replacing Gly88 with an arginine residue (Leland 
et al., 1998). K7AyG88R RNase A is nearly 10-fold more cytotoxic than G88R RNase A 
and nearly equal to Onconase (Haigis et al., 2002). 
1.1.7. Immobilization of RNase A 
RNase A immobilized on a variety of solid supports has been used primarily to 
elucidate mechanisms of enzyme stabilization by immobilization. RNase A immobilized 
on cyanogen bromide activated Sepharose CL-4B exhibited a decrease in specific activity 
relative to the soluble enzyme upon increasing the points of attachment between the 
enzyme and the matrix (Koch-Schmidt & Mosbach, 1977). As the number of attachments 
increased from 1 to 8, the specific activity decreased from 60 to 15 %. However, there was 
a proportionate increase in the thermal stability of the immobilized RNase A coupled by 
multiple linkages. The preparation exhibited a broader endotherm and a higher transition 
temperature (by about 5°C). 
RNase A has been coupled to silica beads with the help of glutaldehyde and 
mechanism of enzyme stabilization studied (Rialdi & Battistel, 1994). A partial 
decoupling of the protein domains as well as a thermal stabilization of the protein 
molecule resulted upon immobilization. One of the two domains of the protein was 
thermally stabilized with respect to the other. The effect is apparently due to favourable 
protein-support interactions rather than to the single-point covalent attachment. 
During the refolding and oxidation of reductively denatured RNase A in solution, there 
is a marked lag in appearance of enzymatic activity as compared to the oxidation of 
sulfhydryl groups, whether such oxidation is spontaneous or is catalyzed by sulfhydryl 
oxidase (Janolino et ai, 1985). However, if RNase A is covalently attached to a 
derivatized glass surface, a lag period is not observed during reformation of native 
structure from the completely reduced, denatured state. Therefore, in solution, 
intermolecular interactions alter the pathway of polypeptide chain folding and disulphide 
bond formation, leading to nonnative disulphides which do not rapidly interchange to form 
native pairings. The seggregation of refolding polypeptide chains by covalent 
immobilization apparently prevents such interactions. 
RNase A immobilized covalently has been shown to exhibit severe loss of activity 
(Messing, 1970; Axen et ai, 1971; Martinez et al, 1990). Since the amino acids most 
amenable to covalent modification (cysteine, lysine, and histidine, and three [Lys7, Lys41, 
and Lys66] of its ten lysines and two [His 12 and His 119] of its four histidines) are also 
critical for ribonucleolytic activity (Raines, 1998). The immobilization of a T45G mutant 
of RNase A via the cysteine residue installed at position 19 facilitated the retention of 
comparatively high ribonucleolytic activity (10 %) and rapid and thorough removal from 
solution (Sweeney et al, 2000). 
1.1.8. Immunogenicity 
RNase A is a good antigen despite its low molecular weight (Smolens & Sevag, 1942). 
Fully methylated RNase A retains nearly 30 % of its immunological activity suggesting 
that the modified protein contains antibody recognizable residual native structure, which 
presumably accomodates some antigenic determinants (Acharya et al, 1977). 
The two hexapeptides NH2-Lys-Asp-Arg-Cys-Lys-Pro-COOH and NH2-Asp-Cys-Arg-
Glu-Thr-Gly-COOH corresponding to the strong hydrophilic regions 37-42 and 83-88, 
respectively, on RNase A were shown to be antigenic, and hence supported the view that 
highly hydrophilic regions on the protein have a good correlation with their potentially 
antigenicity (Sagar et al, 1989). However, antisera raised against the peptide 37-42-RSA 
conjugate did not cross-react with native RNase A but readily cross-reacted with the 
denatured enzyme. This suggested that the site 37-42 is not exposed completely to the 
surface of the molecule and hence unavailable for cross-reaction. X-ray crystallographic 
studies on RNase A have also shown that the region 37-42 is exposed to the surface only 
partially (Kartha et al, 1967). 
1.2. Phosphollpase D 
Phospholipases constitute a diverse series of enzymes that can be classified into 
phosphollpase D, C, A2, Ai and B according to their sites of hydrolysis on phospholipids 
(fig. 3) (Wang, 2001). Phospholipids provide the backbone for biomembranes, serve as 
rich sources of signaling messengers and occupy important junctions in lipid metabolism. 
The activities of phospholipases not only affect the structure and stability of cellular 
membranes, but they also regulate many cellular functions. 
1.2.1. Functions 
Phospholipase D (PLD) (EC 3.1.4.4), is distributed widely both in the plant and animal 
kingdom, and catalyzes the hydrolysis of the terminal phosphodiester bond of 
glycerophospholipids. Because of its additional capability of transferring the phosphatidic 
acid moiety of the substrate to various primary acceptor alcohols, the enzyme is 
predestined for preparation of phospholipids with modified head groups (Eibl & 
Kovatchev, 1981; Shuto et al, 1987). PLD hydrolyzes phosphatidylcholine to produce 
phosphatidic acid and choline. Phosphatidic acid can be further hydrolyzed to 
lysophosphatidic acid by phospholipase A2 or to diacylglycerol by phosphatidic acid 
phosphohydrolase. Lysophosphatidic acid is a known mitogen that interacts with G-
protein-coupled receptors in many cell types (Moolenaar, 1995), and diacylglycerol 
activates protein kinase C (Berridge, 1993). In addition, the stimulation of PLD by small 
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Fig. 3. Hydrolysis of phosphatidylcholine by PLD, PLC, PLA2, PLA,, PLB, 
and lysoPLA and the respective reaction products. The arrow lines for PLD, 
PLC, and PLA2 indicate the site of hydrolysis, but those for PLB, lysoPLA, and 
PLA, do not. PLA, hydrolyzes the sn-1 acylester bond, whereas lysoPLA 
removes the last fatty acid from lysophospholipids that can be produced by PLA2 
and PLA,, as marked by the curved arrows. PLB sequentially removes two fatty 
acids from phospholipids, and its final reaction products are the same as those of 
lysoPLA. Cho, Choline; P-Cho, Phosphocholine; FA, fatty acid. (Wang, 2001). 
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G proteins such a ARP and Rlio suggests that atleast some forms of PLD may be involved 
in intermembrane protein trafficking and cytoskeletal rearrangement (Exton, 1997; Singer 
etal, 1997). 
PLD catalyzed hydrolysis of phospholipids has been observed during seed gemiination, 
aging, and senescence and under a broad spectrum of stress conditions, including freezing, 
drought, wounding, pathogen infection, nutrient deficiency, and air pollution (Chapman, 
1998; Frank et al, 2000; Wang, 2000). Specifically, PLDs play pivotal roles in plant 
response to stresses, and one way in which they achieve this is by mediating the action and 
production of stress-related hormones, abscisic acid (ABA) (Fan et al, 1997; Jacob et al, 
1999), jasmonic acid (Wang et al, 2000), and ethylene (Lee et al, 1998). 
In yeast, PLD is required for the late phases of meiosis and sporulation (Rose et al, 
1995); its function in these processes may result from a role in membrane traficking (Xie 
et al, 1998). In mammalian cells, PLD function is important for various processes, 
including vesicular traficking, secretion, mitogenesis, oxidative burst, and cytoskeletal 
rearrangement (Liscovitch et al, 2000). Activation of PLD produces messengers that in 
turn activate various enzymes such as protein kinases, lipid kinases, phosphatases, and 
phospholipases. A recent study also suggests that PLD activation may promote 
degradation of the translation factor eEFIA (Ransom-Hodgkins et al, 2000). 
1.2.2. Subfamilies 
Based on the requirements for Ca and lipids of in vitro assays, PLDs can be grouped 
into three classes: (a) the conventional PLD that is most active at millimolar levels of Ca ^ 
(20 to 100 mM), (b) the polyphosphoinositide (Pl)-dependent PLD that is most active at 
micromolar levels of Ca , and (c) the phosphatidylinositol (Ptdln)-specific PLD that is 
Ca^^-independent (Wang, 2000). The conventional PLD is the most prevalent and best 
studied class in plants and has been purified to apparent homogeneity from several plant 
sources (Wang, 2000). The Pl-dependent PLD was characterized recently in Arabidopsis 
(Pappan et al, 1997) while the Ptdln-specific PLD was idenUfied in suspension cells of 
Catharanthus roseus (Wissing, 1996). 
According to similarities of deduced amino acid sequence, gene architecture, and 
biochemical properties, PLDs in Arabidopsis are divided in five groups, PLD a, P, y, 5 
and £. Most of the PLDs cloned from other plant species belong to the PLDa group, and 
multiple PLDas have been cloned from cabbage (Kim et al, 1999; Pannenberg et al, 
1998; Schaffner c ' ^^^02), Craterostiga plantagineum (Frank et al, 2000), and rice 
17 
(Morioka et ai, 1997). Two isoenzymes of PLD from cabbage, PLDl and PLD2 have 
recently been identified, on the basis of their cDNAs (Schaffner et al, 2002). Both have 
been assigned to the a-type of plant PLDs. 
1.2.3. Catalysis and substrate specificity 
The hallmark of the PLD superfamily is the consensus motif, H(X)K(X)D, embedded 
within a more loosely conserved region that is usually present in two seperate copies in 
PLD, PSS, and cardiolipin synthases but found as a single copy in the nucleases (Koonin, 
1996; Ponting & Kerr, 1996). The PLDs cloned from eukaryotes all contain two 
H(X)K(X)D motifs, which constitute two active-site regions necessary for PLD activity 
(Xie et al, 2000). Recently, crystal structures have been detennined for a 16-kd 
endonuclease member of the PLD superfamily (Stuckey & Dixon, 1999) and a 54-kd 
bacterial PLD (Leiros et al, 2000) (fig. 4). Such structural information provides valuable 
insights into the mode of action of PLD catalysis. The enzymes of the PLD superfamily 
use a conserved histidine for nucleophilic attack on the substrate phosphorus. PLD 
hydrolyzes phospholipids at the P-0 rather than the C-0 bond via a two-step ping-pong 
reaction mechanism involving a phosphatidylated enzyme intermediate (Stuckey & Dixon, 
1999). 
Most plant PLDs have broad substrate specificity (Abousalham et al, 1991 \ Pappan et 
al, 1998), but different groups of PLDs exhibit varied abilities to hydrolyze different 
phospholipids (Pappan et al, 1998). PLDa, P, and y all utilize phosphatidylcholine, 
phosphatidylethanolamine, and phosphatidylglycerol as substrates, but the substrate 
presentation and Ca^ "^  levels required for PLDp and y are strickingly different from those 
of PLDa (Pappan et al, 1998). In addition, PLDp and y use phosphatidylserine and N-
acyl phosphatidylethanolamine as substrates. Although PLDp and y hydrolyze the same 
substrates, PLDy, but not PLDp, prefers ethanolamine-containing lipids-
phosphatidylethanolamine and N-acyl phosphatidylethanolamine to other lipids. None of 
these cloned PLDs uses phosphatidylinositol 4,5-bisphosphate, or cardiolipin as a 
substrate. In contrast, the Ca^^-independent PLD from C. roseus hydrolyzes 
phosphatidylinositol, but not phosphatidylcholine, phosphatidylethanolamine or 
phosphatidylglycerol (Wissing et al, 1996). The PLD also was reported to lack the 
transphosphatidylation activity characteristic for all other PLDs (Pappan et al, 1998; 
Wang, 2000). Varied substrates specificities and preferences suggest that activation of 
different PLDs may result in 2 hydrolysis of membrane phospholipids. 
18 
Fig. 4. Stereographic illustration of PLD from Streptomyces sp. strain 
PMF coloured from dark blue to red according to the amino acid 
sequence. Two flexible loops (dashed and labeled LI and L2, accordingly) are 
seen at the right side, which is the part of the enzyme that docks onto the 
membrane when hydrolysis takes place. Two phosphate ions (red) are found 
on the surface of the protein, one located at the interface between two 
independent crystallographically related molecules, and the other in the active 
site of the protein, which is located in the center of the figure. (Leiros et al, 
2000). 
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1.2.4. Regulation and Activation 
A number of factors influence the activities of PLD. Notable among these are Ca^ "^  
(Wang, 2000; Zheng et al, 2000), pis (Pappan et al, 1997; Qin et al, 1997), substrate 
lipid composition (Pappan et al, 1998), pH changes (Pappan & Wang, 1999), and 
mastoparan, a tetradecapeptide G-protein activator (Van Himbergen et al, 1999). PLDs 
bind Ca^ "^  and phosphatidylinositol 4,5-bisphosphate (Pappan et al, 1997; Zheng et al, 
2000). Sequence analysis indicates that plant PLDs contain a Ca^Vphospholipid-binding 
fold, called the C2 domain, at the N-terminus (Pappan et al, 1997). The C2 domains of 
PLDa and P have been demonstrated to bind Ca^ '^ and this binding causes conformational 
changes of the proteins (Zheng et al, 2000). PLD|3 C2 have a higher affinity for Ca^ "^ . The 
Ca ^ requirement of PLDa is influenced strongly by pH and substrate lipid composition 
(Pappan & Wang, 1999). PLDa is active at near-physiological, micromolar Ca^ ^ 
concentrations at pH of 4.5-5.0 in the presence of mixed lipid vesicles. In contrast, PLDP 
and a are most active around neutral pH, and their Ca^ "^  requirements are independent of 
pH. 
Intracellular translocation between cytosol and membranes have been proposed as one 
important mechanism of PLD activation (Wang, 2000). The relative distribution of PLD 
between the soluble and membrane fraction changes during development and in reponse to 
stress (Ryu & Wang, 1996; Wang et al, 2000). Study of the Ca^ ^ and C2 domain 
interaction showed that Ca binding increases the affinity of the C2 domains for 
membrane phospholipids (Zheng et al, 2000). This indicates that C2 domains in PLDs is 
responsible for mediating a Ca -dependent intracellular translocation between cytosol and 
membranes. The increased association with membranes of preexisting PLD in the cell may 
represent a rapid and early step in PLD activation in stress responses (Wang et al, 2000). 
In addition, gene expression also plays a role in regulating the cellular levels of some PLD 
isoforms (Wang ct al, 2000). 
1.2.5. Immobilization 
The first extensive study of transphosphatidylation reactions catalyzed by immobilized 
PLD from white cabbage was published by Tobback et al (1988) who investigated many 
different carrier materials for their suitability for the immobilization of the enzyme. These 
included celite, alumina oxide, active carbon (for adsorption), octyl-Sepharose, porous 
glass (for covalent coupling), DF "" "^  "-hadex (ionic binding), Ca ^-alginate, and 
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polyvinylalcohol (entrapment). The quality of biocatalysts obtained was tested by tlicir 
ability to convert dioleoyl-PC into dioleoyl-PE and best results were obtained with PLD 
bound to porous glass or to DEAE-Sephadex. 
Reuter (1997) immobilized PLD from white cabbage on Si02 (Cab-osil M5). For this 
puipose, the Si02 carrier was first derivatized with 3-aminopropyltriethoxysilane or with 
3-glycidoxypropyltrimethoxysi!ane. The highest activities were retained when PLD was 
attached to Si02 functionalized with 3-aminopropyltriethoxysilane. Although the type of 
binding had to be an ionic or adsorptive, significant release of PLD was not observed. 
Lambrecht & Ulbrich-Hofmann (1992) used the property of PLD to bind preferentially by 
adsorption to carriers with hydrophobic surface, and enhancement in binding in presence 
of Ca^ "^  ions for the purificafion of PLD from white cabbage leaves. Other findings of this 
investigation were that the storage stability increased markedly, and a considerable 
broadening of activity profile resulted between pH 5 and 7 (Lambrecht & Ulbrich-
Hofmann, 1993). 
1.2.6. Characteristics of PLD2 
Two isoenzymes (PLDl and PLD2) have been idenfified on the basis of their cDNAs 
(Pannenberg et ai, 1998) from cabbage (Brassica oleracea var. capitata), the tradiUonal 
source for plant PLD (Heller, 1978). The cloning and expression of PLDl and PLD2 has 
recently been successful (Schaffner et al, 2002). The sequence similarity between PLDl 
and PLD2 within the coding regions was determined to be 87.5 % at the nucleotide level 
and 95.8 % at the amino acid level (Pannenberg et al, 1998). The idenfities of the protein 
sequence of PLD2 to other cloned PLD sequences are shown in table 1. 
The genomic structure of PLD2 consists of 3614 bp coding for 812 amino acid residues 
and has a molecular weight of 92.1 kd (Schaffner et al, 2002). The 3614 bp genomic 
DNA contains three intron regions (bp33-bp456, bp560-bp647, bp2554-bp3154). The 
length of mRNA is 2689 bp and the cDNA is 2439 bp. PLD2 is assigned to the a-type of 
plant PLDs. It possesses 8 cysteines, a high proportion of hydrophobic branched chain 
amino acids (21.4 %), and a high proportion of negatively charged amino acids (15 %), 
which is in accordance with its low calculated pi value of 5.37. PLD2 has neither N-
terminal, nor other sequences to target it to nucleus, endoplasmic reticulum, mitochondria, 
peroxisomes, chloroplasts or vacuoles and hence, it is assumed to be a cytosolic enzyme 
(Schaffner e^  a/., 2002). 
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Table 1. Comparison of the amino acid sequence of tlie recombinant PLD2 from 
cabbage witli otiier plant, animal and microbial PLDs. 
Sequence identity 
with cabbage PLD2 (%) 
Ace. Nr 
(NCBI) 
Arabidopsis thaliana (PLDa) 
Arabidopsis thaliana (PLDP) 
Arabidopsis thaliana (PLDyl) 
Arabidopsis thaliana (PLDY2) 
Nicotiana tabacum (PLDa) 
Oiyza sativa (PLDa) 
Oryza sativa (PLDp or y) 
Pimpinella brachycarpa (PLDa) 
Ricinus communis (PLDa) 
Vigna unguiculata (PLDa) 
Zea mays (PLDa) 
Homo sapiens (GPI-PLD) 
Rattus norvegicus (PLD2) 
Arcanobacterium haemolyticum 
Candida albicans 
Corynebacterium pseudotuberclosis 
Corymbacterium ulcerans 
Streptomyces acidmyceticus 
Streptomyces antibioticus 
Streptomyces species 
Strep to verticillium cinnamoneum 
74 
SO 
81 
77 
18 
20 
12 
15 
12 
13 
18 
17 
17 
16 
U96438 
L33686 
U92656 
D73410 
L11701 
P70498 
L16583 
AB010810 
L16586 
L16586 
E03429 
BAA03913 
E05514 
AB007132 
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In accordance with all members of the PLD superfamily, PLD2 is also characterized by 
a duplicated HKD motif (333-348 and 663-680) (fig. 5) (Schaffner et al., 2002). Site-
directed mutagenesis studies on human PLD proved His and Lys of this motif to be 
essential for hydro lytic and transphophatidylation activities (Sung et al, 1997). PLD2 also 
contains a C2 domain (8-153) which binds Ca^ "^  and the binding promotes the associating 
of the protein with membranes. In addition, a phosphatidylinositol 4,5-bisphosphate 
binding site characterized by the motif R/KxxxxRxRK is located in the C2 domain 
(Schaffner et al, 2002). PLD2 shows pH optimum of 5.5 to 5.6 that was not affected by 
upto 100 mM Ca . Ca are however mandatory for activity and stimulation of catalytic 
9-'-
activity approached a maximum at 45 mM Ca" . 
Watanabe et al. (1999) have characterized the PLD expressed in cabbage leaves to be 
PLD2. In presence of 50 mM Ca^ ,^ PLD from cabbage is bound from crude enzyme 
solution to octyl-Sepharose and subsequently selectively eluted by removing the calcium 
ions (Lambrecht & Ulbrich-Hofmann, 1992). PLD from cabbage is active in reverse 
micelles formed from its substrate phosphatidylcholine and triton X-100 in diethyl ether 
(Subramani et al, 1996). The transformation of phospholipids is preferably performed in 
aqueous-organic emulsion systems (Hirche et al, 1997). I,3-diacylgIycero-2-
phosphocholines with acyl chain lengths of Cg-Cig were found to be inhibitors of PLD 
from cabbage (Haftendom et al, 2000). PLD from cabbage was also shown to catalyze the 
transesterification of alkylphosphate esters, which are potent antitumor agents (Aurich et 
al, 1997). 
1.3. Immunoaffinity Immobilization of Enzymes 
The most serious limitation in the long term and large scale applications of enzymes is 
their lability to various forms of inactivation. A number of strategies have been employed 
to improve the stability of enzymes (Wiseman, 1994). One of the most effective among 
these is immobilization on solid surfaces (Gemeiner et al, 1994). Inspite of the 
remarkable achievements in improving the stability of several enzymes by immobilization, 
the mechanisms involved are poorly understood, necessitating individual evaluation of the 
procedure for each enzyme by trial and error. Among the various strategies available for 
favourable orientation of enzymes (Saleemuddin, 1999), the use of monoclonal 
antienzyme antibodies is particularly promising (Solomon et al, 1987; Ruoff e/ al, 1989). 
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Both polyclonal and monoclonal antibodies have been employed in the immobilization of 
enzymes and their relative merits and limitations examined (table 2). 
Heterogeneity of the polyclonal antibody population is however more of a rule than 
exception. Formation of active site recognizing and hence inhibitory antibodies is quite 
likely if an animal is immunized with a native enzyme (Solomon et ai, 1984; Anion, 
1973; Cinader, 1967), although reports describing the non-inhibitory nature of the antisera 
raised against several enzymes are available (Shami et ai, 1991; Jafri et ai, 1993; 
Feinstein et ai, 1971; Ben-Yosef e^  ai, 1975). Some plausible explanations offered for the 
absence of inhibitory antibodies in the antisera include: the active site acting as blind spot 
for the immune system, steric hindrance by high affinity antibodies recognizing adjacent 
locations of active site directed antibodies and continued accessibility of the active site in 
the complex formed between active site recognizing antibodies and the enzyme (Shami et 
al, 1989). Some ingenious techniques for the prevention of the formation of active site 
directed polyclonal antibodies have been described in the recent years. Fusek et al. (1988) 
immunized pigs with active site blocked chymotrypsin prepared by treating the enzyme 
with diisopropylphosphoflouridate. Stovickova et al. (1991) raised non-inhibitory anti-
trypsin antisera with trypsin complexed with its specific inhibitor antilysin. Glycosyl 
recognizing polyclonal anti-invertase antibodies were found to be non-inhibitory towards 
the enzyme and more effective in the immobilization of the enzyme than those 
recognizing the polypeptide domains (Jafri et al, 1995; Jafri & Saleemuddin, 1997). 
Methods also exist for the fractionation of polyclonal antibodies recognizing different 
epitopes of a single antigen or those of differing in affinity for a single epitopes (Suzuki et 
al, 1996;Sadae/a/., 1988). 
Expression of nearly full activity by the enzyme complexed directly with antibody 
(Shami, 1989; Shami, 1991) or when bound to support matrix-coupled antibody have been 
observed (Stovickova et al, 1991). This is due to the fact that, the antibody molecule acts 
as a large spacer holding the enzyme at a distance from the support matrix thereby 
minimizing steric hindrance and facilitating remarkable freedom to act even on high 
molecular weight substrates (Solomon et al, 1986). Enzymes immobilized on antibody 
supports usually exhibit high stability. The stability enhancement may arise out of 
crosslinking like effect caused by antibody binding on enzyme. Shami et al. (1989) argued 
that reduction in the free energy of the antigen resulting from the binding of even a 
moderate affinity antibody may be sufficient to confer stability as free energy changes 
between the folded and the unfolded states of protein lie in the same range (Tc'^ '^^ ''d 
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Table 2. Enzyme immobilized favourably with the help of antibodies (Saleemuddin, 
1999). 
Enzyme 
P-Galactosidase 
Gulonolactone oxidase 
Transglutaminase 
Carboxy peptidase A 
Lactate dehydrogenase 
Glucose oxidase 
Chymotrypsin 
Subtilisin 
Nitrate reductase 
Alpha amylase 
Glucoamylase 
Horse radish peroxidase 
Trypsin 
Urease 
NAD glycohydrolase 
Invertase 
L-Hydantoinase 
Antibody 
PC 
PC 
PC/MC 
MC 
MC 
MC 
PC 
PC 
MC 
PC 
PC 
MC 
PC 
PC 
PC 
PC 
Glycosyl 
specific PC 
PC 
Support matrix 
~ 
-
Agarose beads 
Eupergit C 
Eupergit C 
Sepharose 
Sepharose 
-
Sepharose 
-
-
-
Sepharose 
Nylon 
Nylon 
Sepharose 
Sepharose 
Sepharose 
Stabilization against 
Temperature 
In vivo Proteolysis 
Temperature 
Temperature, pH, Storage in 
cold 
Storage 
Recycling 
-
Sodium hypochloride, 
Temperature 
Temperature 
Temperature, lyophlization. 
Freezing & Thawing 
Temperature, Ethanol 
-
-
pH 
Storage 
Temperature 
Temperature 
Incubation 
Ref. 
Melchers & Messers, 
1970 
Sato & Waltton, 1983 
Ikuraefa/., 1984 
Solomon e/a/., 1984; 
Solomon e/a/., 1987 
Solomon e/a/., 1987 
deAlwise/fl/., 1987; 
deAlwis & Wilson, 
1989 
Fuseke/fl/., 1988 
Shamie/a/., 1989 
Ruoffe/fl/., 1989 
Shamie/fl/., 1989; 
Shamie/a/., 1991 
ShamieM/., 1989; 
Shamie/a/., 1991 
Solomon e/fl/., 1990 
Stovickovae/fl/., 
1991 
Agnellinie/a/,, 1992 
Agnellinie^fl/., 1992 
Mnetai, 1995;Jafri 
& Saleemuddin, 1997 
Siemanne/a/,, 1994 
PC - Polyclonal; MC - Monoclonal. 
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1970). Furthermore, although due to large size of the antibody, a single matrix bound 
antibody may not bind more than one molecule of enzyme, lateral interactions with more 
than one antibody molecule may contribute significantly to the stability of the enzyme 
protein (Sadana & Madgula, 1993). It is interesting to note that some monoclonal 
antibodies exhibit chaperon like activity and assist in antigen refolding (Solomon & 
Schwartz, 1995; Carlson & Yarmush, 1992) and inhibit enzyme aggregation (Katzav-
Gozansky et al, 1996). In instances where soluble antibody is used for the enzyme 
immobilization, a single enzyme molecule may interact with more than one antibody 
molecules resulting in a high degree of stabilization (Shami, 1991) like an enzyme 
attached via multiple covalent (Guisan et al, 1991) or non-covalent linkages (Iqbal & 
Saleemuddin, 1983). While a correlation may exist between the thermal stability of 
proteins and its susceptibility to proteolysis (Daniel et al, 1982), the exact mechanism by 
which antibodies enhance stability against other forms of inactivation is still not clear. 
1.4. The concept of the unfolding region 
The covalent or the adsoptive binding of enzymes to polymers is often, but not always, 
connected with an increase of stability. Ulbrich-Hofmann et al. (1986, 1993) studied the 
themial inactivation of monomeric enzymes e.g a-amylase, trypsin, or chymotrypsin 
before and after immobilization on various polystyrene, silica, or polyacrylamide matrices. 
In all cases, the soluble enzymes were irreversibly inactivated according to first order 
kinetics, whereas the immobilized enzymes, if stabilized, showed a distinct biphasic 
inactivation progress. The inactivation kinetics of the biphasic inactivation curves could 
be excellently fitted by the sum of two exponential terms, where one rate constant was in 
the range of the inactivation constant of the soluble enzyme whereas the second one was 
markedly smaller. The biphasic inactivation kinefics is caused by two enzyme species 
arising as a consequence of immobilization, which differ in stability but not in catalytic 
properties. 
These results led to a model of the unfolding region (fig. 6). It is based on the concep 
that unfolding of an enzyme molecule under denaturing stress starts at a definate region of 
the molecule, denoted as the unfolding region or the labile region. After immobilization, 
the unfolding region of the molecule may be either free or fixed by covalent or 
noncovalent bonds. All molecules, in which the unfolding region is free, are unfolded in 
the same way •^•^'^ v'ith the same rate constant as the soluble enzyme. These molecules 
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SOLUBLE ENZYME 
''"^'Jx i Jr-'-^ fast 
unfolding region 
^ * — i i w 
N^ 
IMMOBILIZED ENZYME 
fast 
slow 
r 
y y 
i \ 
A ^ 
Fig. 6. Models of the unfolding region. Unfolding of the soluble protein molecule is 
initiated at its most labile site. Immobilization results in stabilization if the unfolding 
region is fixed, whereas no stabilization is observed if the unfolding region is free. 
(Ulbrich-Hofmannero/., 1999). 
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represent the iabiie fraction. In the other enzyme molecule, forming the stable fraction, the 
unfolding region is strengthened. Hence according to this model, the unfolding of several 
enzymes may begin at specific labile regions in the molecules and 
modifications/protection of such regions may confer marked stability to them 
(Schellenberger & Ulbrich, 1989; Ulbrich-Hofmann et al, 1993). 
The existence of such labile regions has been demonstrated in a number of enzymes 
including ribonuclease A, ribonuclease B, thermolysin like protease from Bacillus 
stearothennophilus, and hematopoietic cell kinase (Arnold et al, 1996; Arnold et al., 
1998; Eijsink et al, 1995; Engen et al, 1997). It has been shown that a marked 
improvement in the stability of the thermolysin like protease from Bacillus 
stearothennophilus can be achieved by immobilizing the enzyme via the cysteine 
introduced by site directed mutagenesis in the labile region of the enzyme (Mansfeld et 
al, 1999). 
As mentioned earlier, the primary cleavage sites of RNase A vi^ ere determined to be 
Lys31-Ser32 and Arg33-Leu34 for trypsin and Asn34-Leu35 and Thr45-Phe46 for 
thermolysin (Arnold et al, 1996). The structural region from Lys31 to Leu35, together 
with the adjuscent (3-structure containing Thr45-Phe46, therefore presumably represents a 
labile region. Interestingly, naturally occuring RNase B, which has the identical amino 
acid sequence and tertiary structure but is more stable than RNase A, differs by an N-
linked oligosaccharide chain in this unfolding region, at Asn34 (Arnold & Ulbrich-
Hofmann, 1997). In RNase B, the structural region in the vicinity of Lys31 and Leu35 
unfolds first (Arnold et al, 1998). Therefore, the unfolding pathway of RNase A is not 
changed by the carbohydrate attachment and the higher stability of RNase B results from 
the first N-acetylglucosamine residue (Arnold et al, 1999). 
1.5. The present study 
Binding to soluble or matrix associated antibodies has been shown to improve the 
resistance of a number of enzymes to various forms of inacfivation. Both monoclonal and 
polyclonal antibodies (table 2) as well as those raised against the glycosyl residues of 
glycoenzymes have been shown to be quite effective in this regard (Jafri & Saleemuddin, 
1997). More recently F(ab)2 (Jan et al, 2001) and Fab (Gupta et al, 2003) fragments have 
also been used to successfully improve the stability of enzymes. Unlike polyclonals, 
monoclonal antibodies immobilized on appropriate support offer the additional advantage 
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of uniformly orienting enzymes on solid supports (Solomon et ai, 1987; Ruoff et ai, 
1989). 
The proposal of Ulbrich-Hofmann that enzymes contain "labile" region where the 
process of unfolding begins (Ulbrich-Hofmann et ai, 1993) has been substantiated in a 
number of subsequent studies (Arnold et ai, 1996; Mansfeld et ai, 1999). It was therefore 
envisaged that antibodies recognizing the labile region may remarkably stabilize the 
enzyme against thermal and other fonns of inactivation. In addition such antibodies are 
expected to offer the advantage of favourably orienting the enzyme molecules. 
The labile region of RNase A has also been elucidated to comprise of the structural 
region from Lys31 to Leu35, together with the adjacent P-structure containing Thr45-
Phe46 (Ulbrich-Hofmann et al, 1999). Synthetic dodecapeptide corresponding to the 
labile region 32-43 was therefore synthesized chemically to be used as an antigen. The 
peptide corresponding to the N-temiinal 12 residues was also synthesized. The peptides as 
well as native RNase A was used for the generation of antibodies in rabbits. The IgG 
isolated for the immune sera were investigated for their stabilizing potential on RNase A 
and the mutant L35S-RNase A. 
With the aim of locating labile region(s) in a recombinant phospholipase D2 (PLD2) 
from cabbage, limited proteolysis of the enzyme was performed. Thermolysin cleavage 
sites on PLD2 were investigated for the purpose of identifying some loop (weak) regions. 
PLD2 mutants of the cleavage sites were produced to protect the enzyme against 
proteolysis by thermolysin. PLD2 was immobilized onto polyclonal antiPLD2 antibodies 
precoupled to Sepharose to investigate the effect of the immobilization on the stability of 
the enzyme. 
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Materials 
Methods 
2. MATERIALS 
The chemicals used in the present research work were obtained from various sources as 
detailed below. Double distilled water was used in all experiments. 
Chemical 
Acetic acid, Acetone, Disodium hydrogen 
phosphate, Formaldehyde, Glycine, 
Hydrochloric acid, Sodium acetate. Sodium 
carbonate. Sodium chloride. Sodium 
dihydrogen phosphate, Sodium hydrogen 
carbonate, Sodium hydroxide. 
Trichloroacetic acid. 
Acetonitrile. 
Acrylamide, Ammonium persulphate, 
CNBr-activated Sepharose, MonoS, MonoQ, 
N, N'-methylenebisacrylamide, N, N, N', N'-
tetramethylethylenediamine, octyl-Sepharose, 
Protein A-Sepharose, Sephadex G-25, 
Sepharose-4B. 
Agar, Ampicillin, Bromophenol Blue, Calcium 
chloride, Coomassie Brilliant Blue G.250, 
Kanamycin, Lysozyme, PIPES, Thermolysin, 
Sodium dodecylsulphate, Triton X-100, 
Trypsin, Tween 20. 
Agarose. 
4-aminoantipyrin, Bovine serum albumin, 
Cholinoxidase, Chymotrypsin, Dithiothreitol, 
Guanidine hydrochloride, Isopropyl-P-D-
thiogalactopyranoside, 2-mercaptoethanol, 
Peroxidase, Ribonuclease type XII-A, Sodium 
cyanoborohydrate. Sodium deoxycholate, 
TNBS, Tris, Yeast RNA. 
BCA method reagents, B-PER 
Protein Extraction Reagent. 
TM II Bacterial 
Components for growth media, Tryptone, 
Yeast extract. 
Cyanogen bromide. 
l,3-Dipalmitoylglycero-2-phosphocholine 
(1,3-PC). 
Source 
Qualigens Fine Chemicals, India. 
Roth, Germany. 
Pharmacia Biotech., Sweden. 
Serva Feinbiochemica, Germany. 
Eurogentec. 
Sigma Chemical Co., USA. 
Pierce, USA. 
Difco Laboratories, USA. 
Sisco Research Lab., India. 
Synthesized by Haftendom et al. 
(2000). 
DNA sequencing kit 
(SequiThemiExcel Long-Read). 
E. coli strains XL-1 blue and BL21 (DE3), 
Quikchange site-directed mutagenesis kit. 
Ethanol, Glutaraldehyde, Lanthanum ciiioride, 
Phenol, Phenylmethanesulphonylflouride, 
Perchloric acid, TEMED. 
Freund's complete and incomplete adjuvants. 
Goat anti-rabbit immunoglobulin (IgG)-
peroxidase conjugate, Protein markers 
(broad range), Tetramethyl benzidine/H202. 
Glutathione (reduced and oxidized). 
Methanol. 
Microtitre plates. 
Mutagenic primers. 
Nitrocellulose membrane. 
Pfu Turbo DNA polymerase. 
Phosphatidylcholine from egg, 
l,2-Dipalmitoyl-.s«-glycero-3-phosphocholine 
(1,2-PC). 
Phosphatidyl-p-nitrophenol. 
Plasmid isolation kit. 
Plasmid pBXR containing the RNase A gene. 
Plasmid pRSET5a. 
Protein markers (LMW). 
PVDF membrane. 
Restriction enzymes. 
Silver nitrate. 
Uranyl acetate. 
Biozym Diagnostik GmbH, 
Germany. 
Stratagene, USA. 
Merck, Germany. 
Genei Laboratories, India. 
Boehringer Mannheim, Germany. 
Aldrich, Germany. 
Immulon 2 HB, USA. 
MWG Biotech GmbH, Germany. 
Sartorius, Germany. 
Promega Corporation, USA. 
Lipoid KG, Ludwigshafen, 
Germany. 
Synthesized by Dr. Schops 
(Martin-Luther Univ., Germany 
as described by D' Arrigo et al. 
(1995). 
Macherey-Nagel, Germany. 
Ronald T. Raines (WI, USA). 
Institut fur Bioanalytik, 
Gottingen, Germany. 
Amersham Pharmacia Biotech, 
UK. 
Schleicher & Schuell, Germany. 
New England Biolabs. GmbH, 
Gemiany. 
Sigma-Aldrich Laborchemikalien 
GmbH, Germany. 
Loba Chemie, India. 
32 
3. METHODS 
3.1. Studies on RNase A 
3.1.1. Purification of RNase A 
Commercial RNase A gave a single band in the SDS-PAGE and was hence used 
without purification in the initial experiments. The preparation however gave a small 
additional peak on MonoS-FPLC. In the subsequent experiments therefore RNase A was 
used after purification on a 1 ml MonoS-FPLC column equilibrated with 50 mM Tris/HCl 
buffer, pH 8.0. RNase A was dissolved in distilled water and the pH was adjusted to pH 
5.0 with acetic acid. One ml of RNase A sample (1.0 mg/ml) was applied on the column, 
binding was allowed to take place for 2 min and the column eluted with a linear gradient 
of 50 mM Tris/HCl buffer, pH 8.0 containing 0.5 M NaCl. The RNase A peak fractions 
were collected and rechromatographed on the column to ascertain the purity. The 
preparation gave a single band on SDS-PAGE (15 % resolving gel, 5 % stacking gel) 
performed according to the procedure of Laemmli (1970). The movement of proteins was 
from top to bottom. The SDS-gels were stained by Coomassie Brilliant Blue G.250. 
Protein concentration of RNase A samples was determined spectrophotometrically at 278 
nm using the molar extinction coefficient of 9800 M"'cm"^  (Arnold et al, 1996). 
3.1.2. RNase A activity measurements 
RNase A activity was determined spectrophotometrically using yeast RNA as 
substrate (McDonald, 1955). Any fragmented material in the commercial RNA 
preparation was removed by dialysis. The standard reaction mixture in a total volume of 
0.5 ml contained 2.0 mg RNA and appropriate amount of RNase A in 0.1 M sodium 
acetate buffer, pH 5.0. Reaction was initiated by the addition of RNA and incubation at 
37°C for 10 min. The reaction was arrested by the addition of 0.5 ml of MacFadyen's 
reagent (0.25 % w/v uranyl acetate in 2.5 % v/v trichloroacetic acid), the mixture was left 
on ice for 10 min and the precipitate removed by centrifugation (2000 g, 20 min). 
Subsequently, 0.2 ml of the supematent was diluted with 0.8 ml distilled water and the 
absorption of acid soluble ribonucleotides measured at 260 nm. One unit of RNase A is 
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defined as the amount of enzyme required to liberate 1.0 |j,mol of acid soluble nucleotides 
per hour under the assay conditions. The quantity of acid soluble ribonucleotides was 
calculated by assuming a molar absorption coefficient of 10600 M"'cm"' (Curtis et al, 
1966). The specific activity of the commercial RNase A used was 2200 U/mg under the 
conditions. 
3.1.3. Synthesis of peptides 
The dodecapeptides, SRNLTKDRAKPV corresponding to the labile region 32-43 
(Lpep) and KETAAAKFERQG corresponding to the N-terminal region 1-12 (Npep) of 
RNase A were synthesized by solid-phase method using polystyrene CO 1 % (v/v) 
divinyl benzene resin (Stewart & Young, 1984). In the former peptide, cysteine 40 was 
replaced with alanine for the sake of convenience in the synthesis. The crude peptides 
were purified by partition chromatography on Sephadex G-25 (1.2 x 25 cm). 
Concentrations of the synthetic peptides were determined based on the estimation of free 
amino groups (Habeeb, 1966) using glycine as the standard. 
3.1.4. Conjugation of the peptides with BSA 
One milligram of the Lpep or the Npep was conjugated with 3.0 mg of BSA in the 
presence of 0.2 % glutaraldehyde and 50 mM PBS, pH 6.8 in a total volume of 1.0 ml by 
end to end shaking for 90 min at room temperature. Fifty microlitres of 1.0 % NaCNBH4 
was added and the agitation continued for an additional 30 min. The Lpep-BSA and the 
Npep-BSA conjugates thus obtained were stored at -20°C until use. 
3.1.5. Immunization of rabbits 
Rabbits weighing 1.5-2.0 kg were injected subcutaneously with 500 fxg of RNase A, 
Lpep-BSA or the Npep-BSA conjugate (eqv. to peptide weight) using Freund's adjuvant. 
The animals were boosted on day 21 and subsequently bled after a week for monitoring 
the production of RNase A or peptide specific antibodies. 
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3.1.6. Ouchtedony double diffusion 
The formation of RNase A specific antibodies was also determined by the Ouchterlony 
double diffusion method (Ouchterlony, 1949). Glass plates ( 5 x 5 cm) were precoated by 
pouring about 2.0 ml of 0.3 % (w/v) hot agar slurry onto the plates. The agar slurry was 
dried and 8.0 ml of 1.0 % (w/v) hot agar was uniformly layered onto the precoated 
glassplates. Agar was allowed to solidify and wells of uniform size were cut into agar. 
AntiRNase serum (30 |il) was added to the central well while 30 \x\ of RNase A (1.0 
mg/ml) was added to each of the four peripheral wells. The diffusion of antiserum and 
antigen was allowed to take place at 37°C for 3 h, followed by incubation at 4°C for 24 h. 
3.1.7. Enzyme-linked immunosorbent assay (ELISA). 
The generation of antigen specific antibodies were measured in the sera of RNase A, 
Lpep and Npep immunized rabbits by the ELISA. Ninety six-well microtitre plates were 
coated overnight with 100 \i.\ of RNase A, Lpep or the Npep (5.0 i^g/ml) in 0.05 M 
carbonate-bicarbonate buffer, pH 9.6 at 4°C. After extensive washing with PBS-Tween 
20, 100 \i\ of blocking buffer (3.0 % skimmed milk in PBS-Tween 20) was applied to the 
wells and the plates incubated at 37°C for 90 min. After removal of the blocking buffer, 
serially diluted test and control sera were added and binding allowed to proceed at 37°C 
for 2 h. The microtiter plates were washed and incubated with 100 \i\ of HRP conjugated 
goat anti-rabbit IgG at 37°C for 1 h. After the usual washing steps, the peroxidase 
reaction was initiated by the addition of the substrate tetramethyl benzidine/H202, 
arrested by the addition of 4.0 N H2SO4 after 5 min, and absorbance at 450 nm measured 
in an ELISA reader. 
3.1.8. Western blotting 
The generation of RNase A and Lpep specific antibodies were also observed by 
western blotting. SDS-PAGE of RNase A (15 |ag in each well) was performed using 15 % 
seperating and 5 % stacking gels. The protein was transferred from the gel onto 
nitrocellulose membrane. The transfer buffer consisted of 5.8 g Tris / 29.0 g glycine / 400 
ml methanol in a total volume of 2 litres, and the transfer was allowed to take place at 
25 V for 6 h. The membrane was then blocked by 3.0 % skimmed milk in PBS-Tween 20 
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at 37°C for 2 h. After the removal of the blocking buffer, appropriately diluted test and 
control sera were added and binding allowed to proceed at 37°C for 2 h. After washing 
with PBS-Tween 20, incubation with 3000 T diluted HRP conjugated goat anti-rabbit IgG 
was performed at 37°C for 2 h. Subsequent to the usual washing steps, the peroxidase 
reaction was initiated by the addition of the DAB substrate / H2O2 (10.0 mg DAB / 10 |al 
H2O2 in 10 ml water), and arrested by washing the membrane with water. 
3.1.9. Purification of IgG 
The IgG were purified from the immune sera by affinity chromatography following 
the published procedure (Stults et ai, 1989). Briefly, the immune sera raised against 
RNase A or the Lpep were seperately allowed to bind to Protein A-Sepharose packed in a 
small column (5 x 1 cm) at pH 8.9 in presence of 0.1 M Tris/HCl and 3.0 M NaCl. The 
column was washed thoroughly in order to remove any unbound protein. Finally the 
bound IgGs were eluted with 0.1 M glycine/HCl buffer, pH 3.0, and the eluate 
immediately neutralized with the Tris/HCl buffer. Similarly, Npep specific IgG was 
purified on a RNase A-Sepharose column (5 x 1 cm). The purity of the IgGs was 
determined by SDS-PAGE (12 % seperating and 5 % stacking gels). Cross-reactivity of 
the purified IgGs with the respective antigen was also verified by ELISA. Concentration 
of IgG was determined by the procedure of Lowry et al. (1951) using BSA as the 
standard. 
3.1.10. Immobilization of antiRNase and antiLpep-BSA IgG on cyanogen bromide 
activated Sepharose 
The antiRNase IgG and antiLpep-BSA IgG were seperately coupled to CNBr activated 
Sepharose-4B (Porath et al, 1967). Briefly, 1.0 g Sepharose-4B was washed thoroughly 
with water in a sintered glass funnel. The gel was sucked dry and suspended in 1.0 ml 
2.0 M Na2C03. Two hundred mg of CNBr in 0.2 ml acetonitril was added to the 
Sepharose, and activation was allowed to take place at 4°C for 10 min with continous 
stirring. The whole mass was then transferred immediately to a glass sintered funnel and 
washed thoroughly and successively with 0.1 M sodium bicarbonate buffer, pH 8.5, 
distilled water, and once again with the buffer. After thorough washing, the activated 
Sepharose was dried. AntiRNase IgG and antiLpep-BSA IgG (10.0 mg) were seperately 
added to 1.0 gm CNBr activated Sepharose in 0.1 M sodium bicarbonate buffer, pH 8.5 
under stirring for 24 h at 4°C. The Sepharose matrix with bound IgG was seperated by 
centrifugation (3,300 g, 10 min) and protein in the supematent quantitated in order to 
calculate the amount of IgG immobilized. The IgG bound matrix was thoroughly 
washed with 0.1 M sodium bicarbonate buffer, pH 8.5 containing 1.0 M NaCl. Protein in 
the washings was also quantitated. 5.0 ml of this washed suspension was treated with 50 
111 of 98 % ethanolamine for 2 h at 4°C. The IgG bound matrix was successively washed 
with 0.1 M sodium bicarbonate buffer, pH 8.5 containing 1.0 M NaCl, distilled water, and 
finally with 0.1 M sodium acetate buffer, pH 5.0. 
3.1.11. Immobilization of RNase A on antibody supports 
RNase A was immobilized on the antibody supports by incubating 5500 units of the 
enzyme with about 10.0 mg of Sepharose-linked antiRNase and antiLpep-BSA IgG 
respectively in 0.1 M sodium acetate buffer, pH 5.0 for 12 h at 4°C. The matrix was 
separated from the unbound enzyme by centrifugation and washed with the buffer. 
Amounts of the enzyme immobilized were determined by subtracting from the amount 
added those of the supernatant and washing by activity measurements. No attempts were 
made to fully saturate the support surface with the enzyme. The effectiveness factor r\, 
the ratio of actual to theoretical activity of immobilized enzyme (Jafri & Saleemuddin, 
1997) was 0.93 and 0.57 respectively for the RNase A bound to antiRNase and antiLpep 
antibody supports. 
3.1.12. Effect of temperature 
Both soluble and immobilized RNase A preparations were preincubated for 10 min at 
various temperatures ranging between 37-80°C in 0.1 M sodium acetate buffer, pH 5.0. 
The reaction was initiated by the addition of RNA followed by incubation at each 
temperature for 5 min, and arrested by the addition of 0.5 ml of MacFadyen's reagent. 
3.1.13. Effect of pH 
To 250 [xl of RNA (8.0 mg/ml) in 0.1 M NaH2P04 was added increasing volume of 
0.5 M NaOH and the volume made upto 450 |il with water. The volume of 0.5 M NaOH 
was increased in a such a manner that the resulting pH of the solution ranged from 5-10. 
The reaction was initiated by adding 50 \i\ of RNase A (1.1 units) in distilled water 
followed by incubation at 37°C for 5 min. The reaction was terminated by addition of 500 
|al of MacFadyen's reagent. The mixture was left on ice for 10 min and the precipitate 
removed by centrifugation (2000 x g, 20 min). Subsequently, 0.2 ml of the supernatent 
was diluted with 0.8 ml distilled water and the absorbance of the acid soluble 
ribonucleotides measured at 260 nm. Similarly, the effect of pH on the activity of RNase 
A bound to antiRNase IgG-Sepharose or antiLpep IgG-Sepharose was studied, using 
50 fil of the immobilized RNase A preparations (activitywise similar) instead of soluble 
RNase A. 
3.1.14. Proteolysis of soluble and immobilized RNase A preparations by trypsin 
Soluble RNase A and the preparations immobilized on antiRNase IgG-Sepharose or 
antiLpep IgG-Sepharose (2.2 units) were incubated with 0.3 \xg of trypsin in a total 
volume of 200 i^ l in 10 mM phosphate buffer, pH 6.5 at 55°C or at 60°C for various 
durations. The samples were chilled quickly for 15 min and enzyme activity was 
determined after adjusting the pH to 5.0 by adding 0.5 M sodium acetate buffer, pH 5.0. 
In order to ensure that the amount of trypsin does not become rate limiting, the molar 
trypsiniRNase A ratios in these studies were kept very high (1:5.8, 1:6.4 and 1:10.4 for 
soluble RNase A, RNase A immobilized on antiRNase IgG-Sepharose and RNase A 
immobilized on antiLpep IgG-Sepharose, respectively). 
3.2. Studies on L35S-RNase A 
3.2.1. Production of L35S-RNase A 
The RNase A gene was modified by use of the Quickchange site-directed mutagenesis 
kit (Stratagene). The codon CTG for Leu35 was replaced by the codon TCC for Ser. The 
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oligonucleotides 5 '-GATGATGAAGAGCCGGAATTCCACCAAAGATCGATGCAAGC-3' 
(forward) and 5 '-GCTTGCATCGATCTTTGGTGGAATTCCGGCTCTTCATCATC-3' 
(reverse) were used where the nucleotide substitutions are bold-faced. The underlined 
sequences mark the EcoRl restriction site introduced to facilitate the selection of positive 
clones. The mutation was verified by DNA sequencing using the SequiThermExcel 
Long-Read DNA sequencing kit (Biozym) and a Li-COR 4000 DNA-sequencer (MWG). 
The plasmid carrying the correct DNA sequence was transformed into the E. coli 
expression host strain BL2I (DE3). An overnight culture (100 ml TB) of the E. coli 
strain BL21(DE3) carrying the mutated pBXR vector was grown at 37°C with 100 fig 
ampicillin/ml. An aliquot of 10 ml of this culture was used to inoculate 1 litre of TB 
(containing 400 ^g ampicillin/ml). After the cells were grown at 37°C and 200 r.p.m to 
an O.Deoo of 2, expression of the mutant enzyme was induced by addition of isopropyl-P-
D-thiogalactopyranoside to a final concentration of 1 mM. After 4 h of expression, the 
cells were harvested by centrifiigation at 5000 g and 4°C for 15 min. Cell lysis was 
performed in 20 mM Tris/HCl buffer, pH 8.0, containing 10 mM EDTA by treatment 
with lysozyme (1.5 mg/g cells) at 4°C for 1 h and homogenized with a Gaulin 
homogenizer. The inclusion bodies were isolated by centrifiigation at 30,000 g and A°C 
for 30 min and resolubilized in 20 mM Tris/HCl buffer, pH 8.0, containing 6 M GdnHCl, 
100 mM DTT and 10 mM EDTA by stirring at room temperature for 2 h under nitrogen 
atmosphere. After adjusting the pH to 4.0, the protein was dialysed against 2 X 1 0 litres 
of 20 mM acetic acid overnight at 4°C. Precipitate formed during dialysis was removed 
by centrifiigation at 15,000 g and 4°C for 30 min. The protein solution obtained from 4 
litres of culture was added dropwise to renaturation buffer (final volume of 1 litre) with a 
final concentration of 0.1 M Tris/acetic acid, pH 8.5, 0.1 M NaCl, 3 mM reduced 
glutathione (GSH), 0.3 mM oxidized glutathione (GSSG), 10 mM EDTA at room 
temperature and kept for 24 h. The renatured protein was concentrated on a 3 kDa 
membrane using a 400 ml Amicon stirred cell and purified using a MonoS-FPLC column 
which had been equilibrated with 50 mM Tris/HCl, pH 7.5. The elution of the protein 
was carried out with a linear gradient from 50 mM Tris/HCl buffer, pH 7.5, to 50 mM 
Tris/HCl buffer, pH 7.5, containing 0.5 M NaCl. 
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3.2.2. L35S-RNase A assay 
L35S-RNase A (and also RNase A when compared with L35S-RNase A) activity was 
determined spectrophotometrically by using yeast RNA as the substrate (Bergmeyer, 
1984). The standard reaction mixture in a total volume of 0.25 ml contained 100 ^g RNA 
and 0.24 \xg RNase or L35S-RNase in 0.1 M sodium acetate buffer, pH 5.0. The reaction 
was initiated by the addition of RNA followed by incubation at 37°C for 15 min, and 
arrested by the addition of 0.25 ml of stopping reagent (22 mM La^ "^  in 1.2 M perchloric 
acid). The mixture was left on ice for 20 min and the precipitate removed by 
centrifugation (2,000 g, 20 min). Subsequently, 0.2 ml of the supernatant was diluted with 
0.8 ml H2O and the absorbance of the acid soluble ribonucleotides was measured at 260 
nm. 
3.2.3. Immobilization ofL35S-RNase on immunoaffinity supports 
The antiRNase IgG and antiLpep-BSA IgG were seperately coupled to CNBr activated 
Sepharose-4B. L35S-RNase A was immobilized on the antibody supports by incubating 
2146 units of L35S-RNase A with 5.4 mg and 7.1 mg Sepharose-linked antiRNase and 
antiLpep-BSA IgG, respectively, in 0.1 M sodium acetate buffer, pH 5.0 for 12 h at 4°C. 
The matrix was separated from the unbound enzyme by centrifugation and washed with 
the buffer. Amounts of the enzyme coupled were determined by subtracting from the 
amount added those of the supernatant and washing by activity measurements. The 
amount of L35S-RNase A immobilized to antiRNase and antiLpep-BSA antibody 
supports was 105 and 138 units respectively. No attempts were made to fully saturate the 
support surface with enzyme. The effectiveness factor, r], (the ratio of actual to 
theoretical activity of immobilized enzyme) were 0.93 and 0.56, respectively, for the 
L35S-RNase A bound to antiRNase and antipeptide antibody supports. A third 
immobilized complex was prepared by treating the antiRNase IgG-Sepharose with excess 
of the peptide S32-V43 prior to incubation with L35S-RNase A. 
3.2.4. Analysis of aggregation ofL35S-RNaseA 
Two ml of RNase A or L35S-RNase A (6.0 |ig/ml) was incubated in 0.1 M sodium 
acetate buffer, pH 5.0 at 25°C (control) or at 65°C for 1 h. Aggregates were separated by 
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centrifugation at 21,460 g for 30 min, while protein in the supernatant was precipitated by 
sodium deoxycholate precipitation procedure (Arnold & Ulbrich-Hofmann, 1999). 
Protein of the supernatant and of the aggregates was quantified by SDS-PAGE (15 % 
resolving gel, 5 % stacking gel) according to Laemmli (1970), and densitometric 
evaluation of the Coomassie-stained protein bands at 595 nm using a densitometer CD 60 
(Desaga). 
3.2.5. Tit erm al in activation 
(i) Inactivation as a function of temperature. RNase A or L35S-RNase A (1.2 )J.g/ml) in 
0.1 M sodium acetate buffer, pH 5.0 was incubated at different temperatures ranging from 
30 to 70°C for 30 min. After chilling for 5 min, the residual activities were determined at 
37°C. 
(ii) Inactivation kinetics. Both soluble and immobilized L35S-RNase A antibody 
complexes were incubated at 65°C in 0.1 M sodium acetate buffer, pH 5.0 for 0 to 120 
min. After chilling for 5 min, the enzyme activities were determined at 37°C. 
3.2.6. Thermal conformational transition 
Absorbance of RNase A and L35S-RNase A (0.5 mg/ml) in 0.1 M sodium acetate 
buffer, pH 5.0 was measured at 287 nm at different temperatures after equilibration for 5 
min using the spectrophotometer U-2000 (Hitachi). Tm is described as the temperature at 
which half of the protein molecules are in the unfolded state (fN = 0.5). 
3.3. Studies on RNase A aggregation 
3.3.1. Activity measurements 
Activity of soluble RNase A, RNase A bound to antiRNase IgG (molar ratio 1:1) and 
RNase A bound to antiNpep IgG (molar ratio 1:1) was determined by the procedure as 
described in section 3.2.2. 
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3.3.2. Analysis of RNase A aggregation 
RNase A aggregation was studied by incubating 0.75 mg/ml of RNase A in 0.1 M 
sodium acetate buffer, pH 5.0 at 65°C and measuring the absorbance at 350 nm at various 
time intervals. 
Aggregate formation of RNase A was also studied by incubating 0.55 |J.g of RNase A 
in 200 III of 0.1 M sodium acetate buffer, pH 5.0 at 65°C for 0, 1, 3, and 5 h. The tubes 
were chilled over ice and centrifuged at 21,460 g for 30 min. The pellet was dissolved in 
SDS sample buffer and SDS-PAGE performed using 15 % seperating and 5 % stacking 
gels. The gels were silver stained by the method of Nesterenko et al. (1994). Prevention 
of RNase A aggregation by antiRNase IgG or antiNpep IgG was studied by incubating 
RNase A with 6 |ig of IgG (molar ratio 1:1) for 2 h at 37°C prior to heat treatment at 
65°C. Similarly, the RNase A aggregates formed when bound to either IgG were 
analyzed. 
3.4, Studies on the Proteolysis of PLD2 
3.4.1. Production ofPLDl 
PLD2 was expressed in E. coli as described in Schaffner et al. (2002) and purified in 
two steps using the calcium-mediated hydrophobic interaction chromatography on octyl-
Sepharose^*^ CL-4B, Pharmacia, (Lambrecht & Ulbrich-Hofmarm, 1992) and ion 
exchange chromatography on MonoQ (Pharmacia) (Abousalham et al, 1993; Schops et 
al, 2002). octyl-Sepharose column was equilibrated and washed after protein loading 
with 30 mM PIPES, pH 6.2 containing 50 mM CaCli. Subsequently, elution was 
performed with 5 mM PIPES, pH 6.2 containing 0.1 M EDTA. MonoQ column was 
equilibrated and washed after protein loading with 20 mM Tris/HCl, pH 7.5. 
Subsequently, elution was performed with 20 mM Tris/HCl, pH 7.5 containing 2 M 
NaCl. 
3.4.2. Construction and production of PLD2-mutants 
I42S-PLD2, L324S-PLD2 and L288S-PLD2 mutants were constructed by site-directed 
mutagenesis of PLD2 gene in pRSETSa plasmid using the QuikChange Site-Directed 
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Mutagenesis kit (Stratagene). The double mutant L324S/L288S-PLD2 was constructed by 
site-directed mutagenesis of L324S-PLD2 gene in pRSETSa plasmid using the same kit. 
The codon ATT encoding IIe42 was replaced by the codon TCT encoding Ser for I42S-
PLD2. The codon TTG encoding Leu324 was replaced by the codon TCT encoding Ser 
for L324S-PLD2, and the codon CTC encoding Leu288 was replaced by the codon TCC 
encoding Ser for L288S-PLD2. Both these alterations were performed for the double 
mutant L324S/L288S-PLD2. The primers 5'-GTTGAAGAGACATCTGGTTTCGGCAA-3' 
(forward) and 5 '-TTGCCGAAACCAGATGTCTCTTCAAC-3' (reverse) were used for the 
I42S-PLD2 mutant. The primers 5'-GCATAGTCCAAAACTCTCAAGTCTCAGCCAT-3' 
(forward) and 5'-ATGGCTGAGACTTGAGAGTTTTGGACTATGC-3' (reverse) were used 
for the L324S-PLD2 mutant. The primers 5'-
TTTAAAAAAAGACGGTTCCATGGCTACTCAC-3' (forward) and 5'-
GTGAGTAGCCATGGAACCGTCTTTTTTTAAA-3' (reverse) were used for the L288S-
PLD2 mutant. The latter two sets of primers were used for the L324S/L288S-PLD2 
double mutant using L324S-PLD2 gene in pRSETSa plasmid as the template. The 
nucleotide substitutions are bold-faced and the underlined sequences mark the restriction 
site for Muni eliminated to facilitate the selection of positive clones for 142S-PLD2 and 
Ncol introduced to facilitate the selection of positive clones for L288S-PLD2 and 
L324S/L288S-PLD2 mutants. The mutations were verified by DNA sequencing 
according to Sanger et al. (1977) using the SequiThermEXCEL^^II DNA Sequencing 
Kit-LC (Biozym) and a Li-COR 4000 DNA-sequencer (MWG). The plasmids carrying 
the correct DNA sequences were transformed into the E. coli expression host strain BL21 
(DE3) with pUBS 520 (Brinkmann et al, 1989). Expression of the mutated PLD2 genes, 
preparation of crude cell extracts and purification of the mutant enzymes were performed 
essentially as described for the non-modified recombinant PLD2 (3.4.1). 
3.4.3. Protein concentration and enzyme activity 
The protein concentration of PLD2 and PLD2 mutants were determined by BCA 
method as described by Pierce, USA (2000) [cat. # 23225]. 
The hydrolytic activities of PLD2 and PLD2 mutants in aqueous system were 
determined by measuring the p-nitrophenol release from PpNP at 405 nm in a procedure 
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similar to that described by D' Arrigo et al. (1995). The assay mixture consisted of 50 \x\ 
substrate solution (10 mM PpNP, 5 % Triton X-100, 5 mM SDS in 10 mM Tris/HCl, pH 
8.0), 400 lil 0.1 M sodium acetate buffer, pH 5.5 (containing 20 mM CaCb), and 50 \xl 
enzyme solution. After incubation for 10 min at 30°C, the reaction was stopped by the 
addition of 100 |il 1.0 M Tris/HCl, pH 8.0, containing 0.1 M EDTA. One unit of the 
enzyme is defined as the amount required to release 1 |j.mol of p-nitrophenol per minute 
at 30°C. 
Activity staining of PLD2 and its fragments was performed similar to the method of 
Abousalham et al. (1993). Electrophoretic separation on a nondenaturing polyacrylamide 
gel (10 % and 5 % acrylamide for separating and stacking gels, respectively) was 
analogous to the procedure by Novotna et al. (1999), but electrophoresis was run with an 
increasing voltage up to 200 V, to get a constant 6-8 mA current and separation in 
acceptable time. Semidry-Blotting onto nitrocellulose membrane with discontinous buffer 
system was performed as described by Kyhse-Andersen (1984). The membrane was then 
incubated with 1.0 ml of sonificated phosphatidylcholine-suspension (10 mM 
phosphatidylcholine from egg in 0.2 M sodium acetate buffer, pH 5.6, containing 0.1 M 
CaCb) for 30 min at room temperature. It was then carefully covered with 1.0 ml of 
chromogenic mixture (3.0 U/ml cholinoxidase, 0.2 U/ml peroxidase, 5 mM 4-
aminoantipyrin, 8 mM phenol in 10 mM Tris/HCl, pH 8.0) and allowed to stand over 
night. Deep red bands corresponding to PLD activity develop as the membrane dries. 
3.4.4. Limited proteolysis 
30 |al of PLD2 or L324S-PLD2 (1.0 mg/ml) in 50 mM Tris/HCl, pH 8.0, were diluted 
with 240 i^l of 50 mM Tris/HCl, pH 8.0 and equilibrated at room temperature (25''C). The 
reaction was initiated by adding 30 \i\ of 50.0 \iglm\ of trypsin or chymotrypsin in 1 mM 
HCl, or thermolysin in 50 mM Tris/HCl, pH 8.0. After appropriate time intervals, 50 \x\ 
samples were rapidly removed and mixed with 16.7 \i\ 50 mM PMSF, in the case of 
trypsin and chymotrypsin, or 16.7 i^l 50 mM EDTA for thermolysin. The ratio of 
PLD2/protease was optimized with respect to the maximum accumulation of the largest 
fragments as determined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). 
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3.4.5. Electroph oresis 
SDS-PAGE was performed according to the method of Laemmli (1970) using 10 % 
and 5 % acrylamide for the separation and stacking gels, respectively. The molecular 
mass of the fragments were determined from the semilogarithmic plot of the molecular 
masses against the distance of migration using phosphorylase b (97 kDa), albumin (66 
kDa), ovalbumin (45 kDa), carbonic anhydrase (30 kDa), and trypsin inhibitor (20 kDa) 
as marker proteins. 
3.4.6, Matrix-assisted laser desorption/ionization-time of flight mass spectrometry 
(MALDI-TOF mass spectrometry) 
3.4.6.1. In -gel proteolysis 
The bands of PLD2 and its fragments formed after thermolysin cleavage were cut 
out from SDS polyacrylamide gels and washed with water and 50 mM ammonium 
bicarbonate buffer, pH 8.5 (three times, each). After drying under a gentle stream of 
nitrogen, the gel pieces were re-swollen in 30 |il of 50 mM ammonium bicarbonate 
buffer, pH 8.5 and digested overnight with 2 |j,l of trypsin (0.25 p-g/ml) in the same buffer 
at 37°C. 
3.4.6.2. Sample preparation 
A matrix thin layer preparation was carried out as described previously 
(Shevchenko et al., 1996). A saturated solution of a-cyano-4-hydroxycinnamic acid in 
acetone was mixed in a 4:1 (v/v) ratio with a 10.0 mg/ml solution of nitrocellulose 
(Transblot transfer medium, Bio-Rad) in acetone. The matrix (0.5 |il) was deposited onto 
the sample target. 1 )al of the supernatant of the in-gel tryptic digests was injected into a 
small drop of 1.0 % (v/v) trifluoroacetic acid previously deposited onto the matrix surface 
in order to prevent dissolution of the matrix layer by basic pH of the digest solution. The 
sample was allowed to dry and the dried spot was rinsed three times with 10 |il of 0.1 % 
(v/v) trifluoroacetic acid. 
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3.4.6.3. Mass spectrometry 
MALDI-TOF mass spectra were obtained on a Bruker REFLEX mass 
spectrometer (Bruker-Daltonik), upgraded with a gridless delayed extraction ion source 
(pulsed ion extraction). Mass spectra were calibrated using trypsin autolysis products as 
internal standards. 
3.4.7. Semidry blotting for protein sequencing 
PVDF blot-membranes were used for blotting on a Fast-Blot apparatus (Biometra) at 5 
mA/cm^ for 3 h using 50 mM sodium borate, pH 9.0 containing 20 % (v/v) methanol. 
After staining with Coomassie Brilliant Blue (2.5 g Coomassie Brilliant Blue G-250 
dissolved in an aqueous solution containing 40 % ethanol, 10 % methanol, 10 % acetic 
acid, by volume) and gently destaining in an aqueous solution containing 50 % (v/v) 
methanol and 20 % (v/v) acetic acid, the membrane was dried in air and the bands used 
for N-terminal sequencing. Amino acid sequences were determined using the Protein 
sequencer 476A (Applied Biosystems) according to the instructions of the manufacturer. 
3.4.8. Proteolysis of PLD2 treated at various temperatures 
PLD2 (10.0 |ug/90Ml) in 0.1 M Tris/HCl, pH 8.0 was heated at 30, 40 or 50°C for 30 
min, chilled on ice, and proteolysis by thermolysin was performed for 1 h at 25°C by 
adding 10 \i\ of 25.0 |-ig/ml of the protease. The reaction was stopped by adding 33.3 ^1 
of 50 mM EDTA and immediate chilling over ice. 
3.4.9. Proteolysis by thermolysin in the presence ofCa ^ and Net 
Proteolysis of PLD2 by thermolysin in the presence of Ca^* or Na"^  ions was carried 
out as described in section 3.4.4. but 240 yX of 50 mM Tris/HCl, pH 8.0 containing 25 
mM CaCb or NaCl were used. Therefore, the final concentration of CaCl2 or NaCl in the 
reaction mixture was 20 mM. The proteolysis was studied with the PLD2:thermolysin 
mass ratio of 20:1 and 40:1. The samples were preincubated at 4°C for ZQ min in the 
presence of CaCb or NaCl prior to subjecting them to proteolysis. 
3.4.10. Proteolysis ofPLDI in the presence of substrate and substrate analog 
Stock solutions of substrate and substrate analog were prepared by dissolving 10 mM 
1,2-PC or 1,3-PC and 5 mM SDS in 5 mM PIPES buffer, pH 6.2 under ultrasonic 
treatment (300 Ws/ml). Proteolysis of PLD2 by thermolysin was performed as described 
in 3.4.4. but substrate or substrate analog stock solution was added to a final 
concentration of 1 mM 1,2-PC or 1,3-PC. Proteolysis was also carried out in the presence 
of 1 mM 1,2-PC or 1,3-PC and 20 mM CaCb. 
3.5. Studies on immobilized PLD2 
3.5.1. Preparation of immunoaffinity support for PLD2 
Rabbits were immunized with PLD2 by a procedure similar to that described for 
RNase A and the generation of PLD2 specific antibodies was observed by western 
blotting. AntiPLD2 IgG were purified on Protein A-Sepharose column and immobilized 
on CNBr-activated Sepharose. Eight mg of the IgG was added to 1.0 g of CNBr-activated 
Sepharose. Under the conditions 7.5 mg of IgG were bound to Sepharose. 
3.5.2. Immobilization ofPLDl on immunoaffinity support 
Purified PLD2 was immobilized onto antiPLD2 IgG-Sepharose support by a 
procedure similar to that described for RNase A. Briefly, 650.5 munits of PLD2 were 
incubated with 717.0 \xg of Sepharose-linked antiPLD2 IgG in 5 mM PIPES buffer, pH 
6.2. The amount of PLD2 bound was 253.5 munits. The effectiveness factor (r|) was 0.38 
for the PLD2 bound to antiPLD2 IgG-Sepharose. Attempts were also made to bind PLD2 
in crude cell extract to antiPLD2 IgG-Sepharose. 
3.5.3. Immobilization ofPLD2 on cyanogen bromide activated Sepharose 
PLD2 (565.4 munits) was added to 0.2 gm of CNBr activated Sepharose in 0.1 M 
sodium bicarbonate buffer, pH 8.5, under stirring for 24 h at 4°C. The amount of PLD2 
unbound was seperated by centrifugation (3300 g, 10 min) and quantitated by activity 
measurements However, since no PLD2 activity was detected in the unbound sample and 
hence all the enzyme added bound to the matrix. The PLD2 bound matrix was thoroughly 
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washed with 0.1 M sodium bicarbonate buffer, pH 8.5 containing 1.0 M NaCl. 1 ml of 
this washed suspension was treated with 10 [i\ of 98 % ethanolamine for 2 h at 4°C. The 
PLD2 bound matrix was washed successively with 0.1 M sodium bicarbonate buffer, pH 
8.5 containmg 1.0 M NaCl, distilled water, and finally with 5 mM PIPES buffer, pH 6.2. 
The effectiveness factor (rj) was 0.10 for the PLD2 bound covalently to Sepharose. 
3.5.4. Stability of immobilized PLD2 at 50"C 
3.8, 3.2 and 1.4 munits of soluble PLD2, PLD2 bound to antiPLD2 IgG-Sepharose, 
and that bound covalently to Sepharose, respectively, were incubated in a total volume of 
50 (al of 5 mM PIPES, pH 6.2 at 50°C for various durations, and chilled quickly for 5 
min. PLD2 activity was then determined under standard assay conditions. 
3.5.5. Effect of temperature on the activity of soluble and immobilized PLD2 
The activity of soluble PLD2 (3.8 munits), PLD2 immobilized onto antiPLD2 IgG-
Sepharose (3.2 munits) and PLD2 immobilized onto Sepharose (1.4 munits) was 
determined under standard assay conditions but at various temperatures ranging from 25-
70°C. 
3.5.6. Storage stability of soluble and immobilized PLD2 
Soluble and immobilized PLD2 preparations were stored at 6-8°C in 5 mM PIPES, pH 
6.2 buffer, and activity determined each day. The initial activities of soluble PLD2, PLD2 
bound to antiPLD2 IgG-Sepharose, and PLD2 bound to Sepharose were 3.8, 3.2 and 1.4 
munits, respectively. 
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4. RESULTS 
4.1. Studies on RNase A 
4.1.1. Purification of RNase A 
Commercial bovine pancreatic RNase A gave a single band on SDS-PAGE (fig. 7A) 
and hence was used without further purification in the initial experiments. The 
preparation however gave a small peak eluting prior to the major RNase peak on 
chromatography on a MonoS-FPLC column (fig. 7B). Fractions containing the major 
(second) peak containing pure RNase A were collected and used in some studies. 
4.1.2. Kinetic behaviour of RNase A 
The assay for RNase A using yeast RNA as substrate was standardized and the effects 
of time of incubation, enzyme concentration, temperature and pH on the hydrolysis of 
RNA are shown in fig. 8 A, B, C, and D, respectively. From the data, standard assay 
conditions-incubation time (10 min), amount of RNase A (1 |ig), pH (5.0) and 
temperature (37°C) were selected for routine activity measurements. The pH and 
temperature optima of RNase A under the conditions were 8.0 and 60°C, respectively. 
4.1.3. Immunization of rabbits 
RNase A proved to be a good antigen despite its small size. Fig. 9 shows the results of 
Ouchterlony double diffusion (A), Western blotting (B) and ELISA (C) performed to 
demonstrate the presence of antiRNase antibodies in the sera of the immunized rabbits. 
The antiRNase IgG was purified to homogeneity on Protein A-Sepharose column (fig. 
10) and the purity of the IgG ascertained by SDS-PAGE (fig. 11 A). Two bands were 
visible in the SDS-PAGE of IgG and their molecular weight as determined by the 
semilogarithmic plot of the molecular masses against the distance of migration 
corresponded to those of heavy (50 kd) and light chain (25 kd) of IgG (fig. IIB). The 
cross-reactivity of the purified IgG with RNase A was also proved by ELISA. 
The amino acid sequence of the synthetic dodecapeptide that corresponded to the 
labile region of RNase A (Lpep) is; 
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Fig. 7. SDS-PAGE and MonoS-FPLC column chromatography of commercial 
RNase A. The commercial preparation of RNase A was subjected to electrophoresis in 
15 % polyacrylamide gels in presence of 0.1 % SDS and the gels stained with Coomassie 
Blue (A). Both lanes 1 and 2 contained 10 [ig protein. The commercial preparation of 
RNase A was passed through a MonoS-FPLC (1 ml) column (B). Black line indicates the 
elution profile of the commercial preparation, while the elution profile of the pooled 
major peak fraction from the MonoS-FPLC column is shown in red. Inset shows the 
SDS-PAGE of marker proteins (Lane 1) and that of the purified RNase A (Lane 2). While 
a marker protein mixture (10 [ig) was applied on the lane 1, lane 2 contained 5 |jg protein. 
The marker proteins used were phosphorylase b (97 kd), albumin (66 kd), ovalbumin 
(45 kd), carbonic anhydrase (30 kd), trypsin inhibitor (20 kd), and lysozyme (14.4 kd). 
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Fig. 8. Effect of time of incubation (A), enzyme concentration (B), temperature (C) 
and pH (D) on the hydrolysis of RNA. The procedure described by McDonald (1955) 
was followed and details of the reaction cocktails are given in methods section, 3.1.2. 
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Fig. 9. Detection of the antiRNase antibodies in tlie antiserum. Ouchterlony double 
diffusion (A), Western blotting (B) and ELISA (C) were performed to demonstrate the 
presence of antiRNase antibodies. Details are given under methods (section 3.1.6, 3.1.7 
and 3.1.8). 
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Fig. 10. Elution profile of antiRNase A IgG from a Protein A-Sepharose column. 
2.5 ml of the immune serum was loaded on (5 x 1 cm) column and washing performed 
with 0.1 M Tris/HCl buffer, pH 8.9, containing 3 M NaCI. The bound IgGs were eluted 
with 0.1 M glycine/HCl buffer, pH 3,0, and the eluate immediately neutralized with the 
1 M Tris/HCl buffer, pH 8.9 . Fractions of 0.5 ml were collected. 
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Fig. 11, SDS-PAGE of IgG and determination of molecular weight of the IgG. The 
IgG purified from sera of rabbits immunized with RNase A or the Lpep-BSA conjugate 
using a Protein A-Sepharose column was subjected to SDS-PAGE as described in the 
methods, section 3.1.9 (Panel A). Lanes 1 and 4 contain 30 i^ g of standard marker protein 
mixture; myosin (205 kd), phosphorylase b (97.4 kd), BSA (68 kd), ovalbumin (43 kd), 
carbonic anhydrase (29 kd), soyabean trypsin inhibitor (20 kd), lysozyme (14.3 kd), and 
aprotinin (6.5 kd). Lanes 2 and 3 contain 30 |ig each of antiRNase IgG and antiLpep BSA 
IgG, respectively. Panel B shows the semilogarithmic plot of the molecular masses 
against the distance of migration of the standard marker proteins. Protein markers used 
for calibration were phosphorylase b (97 kd), BSA (68 kd), ovalbumin (43 kd), carbonic 
anhydrase (29 kd), soyabean trypsin inhibitor (20 kd) and lysozyme (14.3 kd). Arrows 1 
and 2 indicate the position of the small and large molecular weight peptides, respectively. 
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NH2-Ser-Arg-Asn-Leu-Thr-Lys-Asp-Arg-AIa-Lys-Pro-Val-OH 
(1384.6 daltons) 
Lpep-BSA conjugate was used to raise antibodies in rabbits. Presence of the Lpep-BSA 
specific antibodies was detected by western blotting (fig. 12A) and by ELISA (fig. 12B). 
The binding of antiLpep antibodies to RNase A, however, appeared relatively low as 
compared with that to Lpep (fig. 12B). The cross-reactivity of the antiRNase antibodies 
with the Lpep was demonstrated by allowing these antibodies to interact with RNase A in 
the presence of the peptide. Incubation of whole RNase A with primary antiRNase 
antibodies (antisera) in the presence of Lpep resulted in lower absorbance in the ELISA 
experiments (fig. 13). The decrease in absorbance became more prominent at higher 
dilutions of antisera. The antiLpep-BSA IgGs were also purified on a Protein A-
Sepharose column and the purified fraction cross-reacted well with RNase A as evident 
from the ELISA. 
The sequence of the synthetic dodecapeptide that corresponded to the N-terminal 
region of RNase A (N pep) is; 
NH2-Lys-Glu-Thr-Ala-Ala-Ala-Lys-Phe-Glu-Arg-Gln-Gly-0H 
(1307.4 daltons) 
The binding of the antiNpep antibodies to RNase A appeared to be comparable with the 
binding of the peptide as evident from the ELISA (fig. 14). The antiNpep IgGs were 
purified to homogeneity on a RNase A-Sepharose column. 
4.1.4. Immobilization of RNase A on immunoaffinity supports 
The IgG isolated from the sera of rabbits immunized either with the native RNase A or 
the Lpep when coupled to CNBr activated Sepharose were effective in binding RNase A 
from solution. As shown in table 3, the supports bearing antiLpep and antiRNase IgG 
bound comparable quantities of RNase A but the immobilized preparations differed 
markedly with regard to the effectiveness factor (Iqbal & Saleemuddin, 1983b). The r\ 
values for RNase A bound to antiRNase IgG and antiLpep IgG supports were 0.93 and 
0.57, respectively. 
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Fig. 12. Western blot analysis and ELISA of antiLpep-BSA antiserum. For western 
blotting, RNase A was subjected to SDS-PAGE and transferred on to a nitrocellulose 
sheet. The sheet was incubated with antiLpep-BSA antiserum followed after washing 
with the HRP conjugate (Panel A). Panel B ELISA shows the cross-reactivity of 
antiLpep-BSA antiserum with the Lpep and whole RNase A. AntiLpep-BSA antiserum 
with the Lpep (•); antiLpep-BSA antiserum with the whole RNase A (O). Antigen amount 
coated was 0.5 |ig of RNase A or the peptide. See methods for details (section 3.1.7 and 
3.1.8). Each point represents the average of three independent determinations. 
S.E.M.:± 0.021. 
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Fig. 13. Cross-reactivity of the RNase A specific antibodies with the Lpep. RNase A 
(0.5 |ig/well) was coated on the ELISA plate as described in the methods, section 3.1.7. 
The plate was processed for the usual ELISA steps to show the specificity of antisera 
with RNase A. Different dilutions of RNase A specific antisera were incubated in the 
presence/absence of the peptide. Finally the plate was developed with the colouring agent 
and absorbance of the coloured complex was measured at 450 nm. Antiserum without 
peptide (o), antiserum with peptide (3 i^g/well) (•). 
57 
o 
in 
20x10^ 40x10' 60x10' 80x10' 
AntiRNase antiserum dilution 
100x10' 
Fig. 14. ELISA showing the cross-reactivity of antiNpep-BSA antiserum with the 
Npep or RNase A. AntiNpep-BSA antiserum with the Npep (•), antiNpep-BSA 
antiserum with whole RNase A (0). Wells were coated with either 0.5 ^g of RNase A (O) 
or the Npep (•). ELISA was performed as described in methods (section 3.1.7) using 
antiNpep-BSA antiserum. Each point represents the average of three independent 
determinations. 
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Table 3. Immobilization of RNase A on CNBr activated and antibody coupled 
Sepharose supports. 
Sepharose support 
AntiRNase IgG coupled (10 mg/g) 
AntiLpep IgG coupled (9.5 mg/g) 
RNase A bound (U/ml) 
Theoretical (a) Actual (b) 
242.0 
224.4 
308.0 
176.0 
Effectiveness factor 
Ti (b/a) 
0.93 
0.57 
Each value represents the mean of three independent determinations. Maximum variations 
did not exceed ± 6.6 units. 
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4.1.5. Stability of immunoaffinity immobilized RNase A 
4.1.5.1. Effect of temperature 
The temperature-activity profiles of soluble and various immobilized RNase A 
preparations are shown in fig. 15. While immobilization on the antibody supports did not 
alter the optimum temperature (60°C) of RNase A, the immobilized preparations retained 
a far greater fraction of activity at higher temperature as compared to the soluble enzyme. 
At 70°C the RNase A immobilized on Sepharose supports precoupled either with 
antiRNase antibodies or antiLpep antibodies retained over 90 % activity while the soluble 
enzyme retained less than 70 %. The immobilized preparations also appeared 
significantly more stable at 80°C, and the fraction of activity retained at this temperature 
was higher in case of RNase A immobilized on the antiRNase antibody supports. Under 
the conditions the soluble, antiLpep antibody support bound and antiRNase antibody 
support bound RNase A preparations retained 24, 35 and 49 % of their initial activity. 
4.1.5.2. Effect of pH 
The pH activity profile of soluble and various immobilized RNase A preparations are 
shown in fig. 16. Immobilization on antibody support did not alter the optimum pH (pH 
8.0) of RNase A. The immobilized preparations however showed the marginal 
broadening of the profile both in acidic and alkaline range as compared to the soluble 
enzyme and the immobilized preparations retained greater fraction of activity both in 
acidic and alkaline range. The support bearing the anfiLpep antibodies were superior in 
protecting the bound RNase A from inactivation, both in the acidic and alkaline range 
than the support bearing antiRNase antibodies. The activity retained at pH 5.0 was 13, 28 
and 38 % for soluble, antiRNase antibody support bound and antiLpep antibody bound 
RNase A preparations, respectively; at pH 10.0, the respective values were 40, 54 and 
59 %. 
4.1.5.3. Effect oftrypsinization 
The support bearing the antiLpep antibodies was clearly superior in protecting the 
bound RNase A from trypsin induced inactivation at 55°C (fig. 17A). RNase A is 
recalcitrant to trypsin action at moderate temperatures but is readily fragmented and 
inactivated above 50°C by the enzyme (Arnold et al, 1996). As shown in fig. 17A, less 
than 30 % activity of soluble RNase A is retained on incubation at 55°C for 30 min with 
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Fig. 15. Effect of temperature on the activity of soluble and immobilized RNase A. 
Appropriate quantities of soluble and of immobilized RNase A preparations were 
incubated with 2 mg of RNA in a total volume of 0.5 ml at the indicated temperatures for 
5 min in 0.1 M sodium acetate buffer, pH 5.0. The preparations of RNase A investigated 
were: soluble (•), those immobilized on antiRNase IgG-Sepharose (O), and on antiLpep 
IgG-Sepharose (v). Each point represents the mean of three experiments carried out in 
triplicates. S.E.M.: ± 1.43. 
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Fig. 16. Effect of pH on the activity of soluble and immobilized RNase A. Activity of 
soluble and of immobilized RNase A preparations were determined between pH 5-10 as 
described in methods section, 3.1.13. The preparations of RNase A investigated were: 
soluble (•), immobilized on antiRNase IgG-Sepharose (#), and immobilized on antiLpep 
IgG-Sepharose (y). 
62 
> 
• > 
o 
< 
"(5 
"w 
pH 
Fig. 17. Effect of trypsin on soluble and immobilized RNase A. Time reactions were 
performed by incubating 2.2 units of soluble and immobilized RNase A preparations with 
0.3 |.ig of trypsin in a total volume of 0.2 ml of 10 mM phosphate buffer, pH 6.5 either at 
55"C (A) or at 60"C (B). The preparations of RNase A investigated were: soluble (•), 
antiRNase IgG-Sepharose immobilized (#), and antiLpep IgG-Sepharose immobilized 
(T). The loss of activity was determined as described in methods section, 3.1.14. Each 
point represents the mean of three experiments carried out in triplicate. S.E.M.: ± 1.06. 
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trypsin. Under the condition the enzyme bound to the antiRNase antibody support 
retained over 40 % activity while that bound to the antiLpep antibody support retained 
over 80 %. The enhancement in the resistance of the immobilized preparation to trypsin 
induced inactivation was, however, of far lower magnitude at 60°C. As shown in fig. 
17B, the antiRNase antibody support bound enzyme retained higher activity than the 
soluble enzyme and the antiLpep antibody support bound enzyme retained higher activity 
than the latter, especially after incubation for smaller durations at 60°C. 
4.2. Studies on L35S-RNase A 
The mutant enzyme L35S-RNase A (fig. 18) was expressed in E. coli as inclusion 
bodies as reported earlier by Markert et al. (2001). After renaturation and purification, the 
enzyme migrated as a single band in SDS-PAGE with mobility indistinguishable from 
that of the purified RNase A. The mutation is not located in or the proximity of the active 
site, but the enzyme activity of L35S-RNase A was only 43 % as compared to that of the 
wild type enzyme (table 4). 
4.2.1. Inactivation and conformational transition of RNase A and L35S-RNase A as a 
function of temperature 
A marked influence of the mutation was observed on thermal stability of the enzyme. 
Fig. 19 shows the inactivation of RNase A and L35S-RNase A exposed to various 
temperatures for 30 min. As compared to RNase A, the activity retained by L35S-RNase 
A was remarkably low between 40 and 70°C. Thus while RNase A retained complete 
activity after exposure to 50°C, the L35S-RNase A lost over 75 % activity. The thermal 
transition of RNase A and L35S-RNase A as revealed by UV-spectroscopy, also 
indicated lower stability of the mutant enzyme (fig. 20). The difference in transition 
temperatures (Tm) of RNase A and L35S-RNase A amounted to 9.0^0 at pH 5.0 (table 4). 
4.2.2. Analysis of aggregation 
To investigate if the observed low stability of L35S-RNase A is related to an enhanced 
tendency of the enzyme to aggregate, the aggregation behaviour of L35S-RNase A and 
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Fig. 18. Tertiary structure of RNase A. The model was taken from the Brookhaven 
protein data bank and drawn with RASMOL, a-hehces and P-sheets are presented as 
ribbons. 
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Table 4. Specific activity and Tm of RNase A and L35S-RNase A. 
Parameter 
Specific Activity (U/mg) 
Tn, rc) 
RNase A 
5008 ±8 
58.8 ±0.2 
L35S-RNase A 
2146 ±16 
49.8 ± 0.2 
One unit of RNase A activity is defined as the amount of enzyme required to 
liberate 1 i^ mol of acid soluble nucleotides per hour under the assay 
conditions. Tm value was determined as described in the text. 
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Fig. 19. Effect of temperature treatment on the activity of RNase A (o) and L35S-
RNase A (•). 0.24 [ig of RNase A (4.8 U/ml) or L35S-RNase A (2.1 U/ml) was 
incubated in a total volume of 0.2 ml in 0.1 M sodium acetate buffer, pH 5.0 at different 
temperatures ranging from 30 to 70°C for 30 min. The samples were chilled for 5 min 
and activity determined under standard assay conditions at 37°C. Each point represents 
the mean of two experiments carried out in triplicate. S.E.M.: + 2.35 
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Fig. 20. Thermal transition of RNase A (o) and L35S-RNase A (•) at pH 5.0. The 
absorbance of RNase A and L35S-RNase A was measured as described in methods 
section, 3.2.6, and the fraction of the enzyme in the native state (fn) was plotted against 
temperature. 
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RNase A at 25 and 65°C was quantified by electrophoresis and scanning of the gels after 
Coomassie Blue staining (fig. 21). At 25°C, only a small fraction of protein (11 % for 
RNase A and 8 % for L35S-RNase A) was found to aggregate but the aggregation 
increased to 20 % for RNase A and 23 % for L35S-RNase A, respectively, after treatment 
at 65°C for one hour. Thus, the aggregation behaviour of L35S-RNase A appeared 
comparable with that of RNase A. 
4.2.3. Inactivation kinetics of soluble and immunoaffinity immobilized L35S-RNase A 
To investigate the effects of antibodies on enzyme stability, L35S-RNase A was bound 
to Sepharose matrices precoupled either with: antiLpep-BSA IgG which recognizes the 
S32-V43 region of RNase A, antiRNase IgG or antiRNase IgG pretreated with the 
peptide S32-V43. All the three immobilized preparations retained a far greater fraction of 
activity after heat treatment at 65°C as compared to the soluble enzyme (fig. 22). The 
support bearing the antiLpep-BSA IgG, however, was clearly superior in protecting the 
L35S-RNase A from thermal inactivation. After 2 h of heat treatment at 65°C, the activity 
retained by L35S-RNase A immobilized on Sepharose supports precoupled with 
antiLpep-BSA IgG, antiRNase IgG or antiRNase IgG with blocked labile region was 
100 %, 58 % and 39 %, respectively. The soluble enzyme retained less than 20 % activity 
under these conditions. 
4.3. Studies on RNase A aggregation 
As shown in fig. 21, RNase A undergoes aggregation only moderately at 65°C in one 
hour. The aggregation of RNase A at 65°C till 5 h was also studied by following 
absorption at 350 nm where only aggregates but not soluble RNase A absorb (fig. 23). 
The absorbance of RNase A at 350 nm increased with time although slightly and 
gradually, suggesting the formation of small amounts of aggregates. RNase A does not 
stick on the walls of the eppendorf at 65°C (fig. 24A). 
Both antiRNase and antiNpep antibodies decreased RNase A aggregation at 65°C, but 
the former appeared more effecdve (fig. 24B). The bands corresponding to the aggregates 
increased from 0-5 h of incubation at 65°C. The RNase A aggregate formed at 65°C in 
^o 
Fig. 21. Detection of RNase A and L35S-RNase A aggregation by SDS-PAGE at 
ISX (control) and after 1 h treatment at 65°C. 12 [xg of RNase A or L35S-RNase A 
was incubated in a total volume of 2 ml in 0.1 M sodium acetate buffer, pH 5.0 at 25°C 
or 65°C as described in methods section, 3.2.4. Lane 1, molecular weight markers; lane 2, 
RNase A in 25°C supernatant; lane 3, RNase A in 25°C aggregates; lane 4, RNase A in 
65'^ C supernatant; lane 5, RNase A in 65°C aggregates; lane 6, L35S-RNase A in 25°C 
supernatant; lane 7, L35S-RNase A in 25°C aggregates; lane 8, L35S-RNase A in 65°C 
supernatant; lane 9, L35S-RNase A in 65°C aggregates. 
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Fig. 22. Thermal inactivation of soluble and immobilized L35S-RNase A 
preparations at 65°C. Appropriate quantities of soluble and immobilized preparations 
were incubated at 65°C in 0.1 M sodium acetate buffer, pH 5.0 for the indicated time 
periods. After chilling for 5 min, enzyme activity was determined under standard assay 
conditions at 37°C. The preparations of L35S-RNase A investigated were: soluble (•), 
antiLpep-BSA IgG-Sepharose immobilized (v), antiRNase IgG-Sepharose immobilized 
(O), and antiRNase IgG (with blocked labile region specific IgG)-Sepharose immobilized 
(T). Each point represents the mean of three experiments carried out in duplicates. 
S.E.M.: + 3.63 
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Fig. 23. Aggregation of RNase A at 65''C. RNase A (0.75 mg/ml) in 0.1 M sodium 
acetate buffer, pH 5.0 was incubated at 65°C at various time intervals ranging from 
0-300 min and the absorbance at 350 nm was measured. 
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Fig. 24A. Lack of adhesion of RNase A on the eppendorf tubes. 0.55 \ig of RNase A in a 
total volume of 200 |il of 0.1 M sodium acetate buffer, pH 5.0 was exposed to 65°C for 1 h 
(lanes 1 and 4), 3 h (lanes 2 and 5) or 5 h (lanes 3 and 6). The samples in lanes 1-3 were 
collected by centrifugation at 21,460 g for 30 min and dissolved in SDS sample buffer and 
subjected to electrophoresis. The samples in lanes 4-6 were removed from the eppendorfs 
and the sample buffer containing SDS was added to the tubes, shaken thoroughly and used 
for electrophoresis. 
Fig. 24B. Aggregation of RNase A in presence of antibodies at 65°C. 0.55 jig of RNase 
A or 0.55 fig of RNase A and 6 |ig of IgG in a total volume of 200 ixl of 0.1 M sodium 
acetate buffer, pH 5.0 was incubated at 65°C for various time intervals as described in 
methods section, 3.3.2. SDS-PAGE of RNase A exposed to 65°C in absence (lanes 3-5) or 
presence of antiNpep IgG (lanes 7-9) or antiRNase IgG (lanes II-I3). Samples in the lanes 
3, 7, 11 were exposed to the temperature for 1 h, 4, 8, 12 for 3 h and 5, 9, 13 for 5 h. 
Samples in lane 2, contained RNase A, in lane 6, contained RNase A + antiNpep IgG, lane 
10, contained RNase A + antiRNase IgG. Details are given under methods section, 3.3.2. 
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presence of antiNpep antibodies decreased markedly, wliereas very little aggregation was 
observed in presence of antiRNase antibodies. 
4.4. Studies on the Proteolysis of PLD2 
PLD2 was expressed in E. coli BL21 (DE3) cells harbouring the plasmid pUBS520 
(Brinkmann et al, 1989) as described by Schaffner et al. (2002). The success of 
expression was evident from the observed PLD hydrolytic activity in the crude cell 
extract. Purification of PLD2 from the E. coli BL21 (DE3) extract was performed on a 
octyl-Sepharose column chromatography followed by MonoQ HPLC. PLD2 fractionated 
on octyl-Sepharose column contained an additional 30 kd protein (fig. 25A) which was 
removed during MonoQ HPLC to obtain a homogenous PLD2 preparation (fig. 25B). The 
molecular mass of PLD2 was determined by SDS-PAGE to be 87 kd while that calculated 
from the amino acid sequence is 92 kd (Schaffner et al, 2002). 
4.4.1. Proteolysis ofPLDl by trypsin and chymotrypsin 
Native PLD2 proved to be extremely sensitive to proteolytic attack. Chymotrypsin and 
trypsin, inspite of their high bond specificities (for aromatic or basic amino acids 
respectively), degraded PLD2 to small fragments even at room temperature (25°C) (fig. 
26). All attempts to isolate large fragments reflecting the primary cleavage site(s) were 
however, unsuccessful inspite of the large number of experiments performed in which the 
enzyme was exposed to the protease for various durations (15 s to 8 h), at several 
enzyme ; protease mass ratios (10-100). Chymotrypsin and trypsin were not considered 
suitable for the identification of the primary cleavage sites, for the localization of the 
most vulnerable region(s). 
4.4.2. Proteolysis of PLD 2 by thermolysin 
Surprisingly, thermolysin with known broad bond specificity degraded native PLD2 
gradually and caused the accumulation of large polypeptide fragments, (fig. 27 and the 
left part of fig. 32 [lanes 2-7]). Band I was nearly indistinguishable from PLD2 in its 
migration in the gei but was identified as an N-terminaiiy shortened PLD2 as described 
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Fig. 25A. Purification of PLD2 expressed in E. coli BL21 (DE3) cells using octyl-
Sepharose. The lysate of E. coli (15 ml) was dialyzed against 30 mM PIPES, pH 6.2 
containing 50 niM CaCl2 and loaded on an octyl-Sepharose column and eluted as described 
in the methods section, 3.4.1. Fractions of 5 ml were collected and subjected to SDS-PAGE. 
Lane 1, crude cell extract (5 jil); lanes 2-7, eluted fractions 12-17 (20 |il); lane 8, molecular 
mass markers (1 (ig). 
Fig. 25B. Purification of PLD2 expressed in E. coli BL21 (DE3) ceils using MonoQ. The 
fractions 13 and 14 from (A) were pooled, dialyzed against 20 mM Tris/HCl buffer, pH 7.5 
and loaded on the MonoQ column and eluted as described in the methods, section 3.4.1. The 
wash (10 ml) and eluted (5 ml) fractions were collected and subjected to SDS-PAGE. Lane 1 
and 8, molecular mass markers (1 |ig); lanes 2-4, wash fractions 7-9 (20 i^ l); lanes 5-7, 
eluted fractions 16-18 (20 |al). 
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Fig. 26. Proteolysis of PLD2 by chymotrypsin and trypsin at 25''C. PLD2 was 
incubated witli proteases at a mass ratio 1:40. The samples were subjected to SDS-PAGE 
as described in the methods section, 3.4.5. Lane M, molecular mass markers (5 (ig) 
[phosphorylase b (97 kd), albumin {66 kd), ovalbumin (45 kd), carbonic anhydrase 
(30 kd), and trypsin inhibitor (20 kd)]; lanes 1, 2, 3, 4, 5 and 6 contain samples of PLD2 
(5 |ig) exposed to trypsin and lanes 1', 2', 3', 4', 5' and 6', PLD2 (5 |j,g) samples exposed 
to chymotrypsin for 1,5, 10, 30, 60 min and 8 h, respectively. 
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Fig. 27. Proteolysis of PLD2 by thermolysin at 25"C. PLD2 was incubated with 
thermolysin at a mass ratio 20:1. The samples were subjected to SDS-PAGE as described 
in the methods section, 3.4.5. Lane 1, molecular mass markers (10 (ig); lanes 2, 3, 4, 5 
and 6, PLD2 (5 |ig) exposed to themioiysin for 0, 5, 30, 60 and 240 min, respectively. 
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below. With increasing time, two other bands, II and III, accumulated. On longer 
incubation the band II was converted into band III and finally to band IV and several 
other bands corresponding to peptides < 35 kd. 
The molecular masses of the peptide fragments represented in bands I - IV were 
respectively 81, 63, 58 and 37 kd as determined from tlie migration behaviour of standard 
proteins. The activity of PLD2, which was to 9.5 U/mg prior to incubation with 
thermolysin, dropped within 5 minutes of proteolysis to < 5 % of the initial activity. This 
shows that even the peptide(s) constituting band I were catalytically inactive. 
The pattern of fragment fomiation by the action of thermolysin was approximately the 
same when proteolysis was performed at 37°C, whereas no larger fragments accumulated 
on proteolysis at 50°C. Bands I - IV formed at 25°C (fig. 27) were further analyzed to 
identify the initial cleavage sites of native PLD2 by thermolysin. 
4.4.3. Fragment analysis 
To obtain information on the region of PLD2 that gave rise to bands I - IV (fig. 27), 
the bands were eluted from the gel and analyzed by MALDI-TOF mass spectrometry 
after in-gel proteolysis by trypsin. The resulting masses were compared with those of 
peptides that are possibly formed by trypsin cleavage of PLD2. 
Table 5 lists all expected peptide fragments of PLD2 and their respective masses that 
could be found in at least one of the experimentally studied samples. From the results, it 
can be concluded that the cleavage site leading to the formation of the pepfide in band I 
was located prior to the amino acid residue (a.a.) 67, and that leading to the formation of 
the peptides in bands II and III before the a.a. 369. The pepfide of band III had a C-
terminal deletion after the a.a. 795 but it could not be clearly be ascertained if in the 
pepfide of band I also the C-terminal a.a. 795-812 are missing. Because of the intact C-
terminus of the band II peptide, it was assumed that also the first peptide fragment 
represented by band I sfill has the a.a. 795-812 but it was difficult to detect the peptide in 
MALDI-TOF mass spectroscopy. Band IV (corresponding to 37 kd pepfides in SDS-
PAGE) obviously represents an overlap of two or more fragments and was not further 
analysed. On the basis of mass estimation, band IV might contain peptide fragments 
covering the sequences Ile42-Asn323 (35.9 kd) and Ile500-Arg797 (34.6 kd). 
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Table 5. Tryptic peptides of PLD2 and its fragments formed after proteolysis by 
thermolysin as determined by MALDI-TOF mass spectrometry". 
Peptide sequence m/z [M + H] m/z[M + H] detected 
expected expected PLD2 band I band IT band III band IV 
1-26 
47-59 
67-73* 
98-109 
126-134 
126-142* 
147-156 
147-163* 
167-178 
167-182* 
183-198 
225-242 
269-277 
313-335 
336-353 
369-378 
379-400 
401-413* 
414-429 
471-496 
503-513 
569-594 
619-629 
657-665* 
666-684 
691-707 
748-771* 
772-795 
798-812* 
2854.48 
1479.77 
830.46 
1241.65 
1160.56 
2022.99 
1211.60 
2041.00 
1445.72 
1861.90 
1770.92 
2164.18 
1128.64 
2523.20 
1845.90 
1282.62 
2481.18 
1534.75 
1949.98 
2373.16 
1286.69 
2969.52 
1347.65 
1180.63 
2181.07 
1934.89 
2891.40 
2715.28 
1656.96 
X 
X 
-
X 
X 
X 
X 
-
-
X 
X 
X 
X 
X 
X 
X 
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X 
X 
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X 
X 
X 
-
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X 
-
-
X 
-
X 
X 
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X 
-
X 
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X 
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-
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^ Amino acid positions of the peptides correspond to those of the sequence of PLD2 (P55939) in 
the SWISS-PROT database. Expected masses were calculated by the program "Peptide Mass" 
(www.expasy.ch). Crosses mark masses of peptide ions detected. 
'' Stars mark masses of peptide ions in which one tryptic cleavage site was missed. 
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In order to deteiTnine the exact N-terminus of the fragments arising from native PLD2 
by thermolysin, the bands I, II and III were blotted and the resulting peptides were N-
terminally sequenced (fig. 28A). From the results (table 6), the first cleavage yielding 
peptide I was derived to be between Thr41 and Ile42, while the second yielding peptide II 
was identified to lie between Asn323 and Leu324. Peptide III had the same N-temiinus 
(Leu324) as peptide II but lacks the C-termina! peptide corresponding to a.a. 798-812 as 
was observed by the results of MALDI-TOF-MS (table 5). The third cleavage site was 
therefore suggested to be Lys795-Ala796 or Arg797-Ile798. 
PLD activity of bands I-IV were examined by activity staining experiments as 
described in section 3.4.3. While intact PLD2 could be distinctly stained in the gels, none 
of the fragments exhibited activity (fig. 28B). 
4.4.4. The effect of pre-heating on proteolysis 
The degradation of PLD2 by thermolysin after the enzyme was preincubated at 30, 40 
or 50°C for 30 min is shown in fig. 29. With increasing preincubation temperature, a 
progressive loss of bands I, II and III was observed. After exposure to 50°C, the bands 
completely disappeared, except for some traces of low molecular weight bands including 
band IV. 
4.4.5. The effect of calcium ions, substrate and substrate analogs on the proteolytic 
susceptibility ofPLD2 
Calcium ions exerted a remarkable effect on the proteolysis of PLD2 by thermolysin. 
Surprisingly, proteolysis at a PLD2:thermolysin mass ratio of 40:1 was strongly 
stimulated in the presence of 20 mM CaCl2 (fig. 30). At a PLD2:thermolysin mass ratio of 
20:1 in analogy to fig. 27, the proteolysis was extremely fast in the presence of 20 mM 
CaCl2 (data not shown). Within 5 min band I completely disappeared, whereas the band 
was detectable in the absence of CaCli for more than 1 h. Inclusion of 20 mM CaCli in 
the reaction mixture did not alter the pH and raising of ionic strength by inclusion of 
20 mM NaCl instead of CaCb did not result in the stimulation of proteolysis. This 
suggests that the destabilizing effect is related to a specific effect of calcium ions on the 
conformation of PLD2. 
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Fig. 28. Blot of PLD2 and its fragments formed after proteolysis by thermolysin. 
Native PLD2 and PLD2 exposed to thermolysin were subjected to SDS-PAGE and 
blotted on a PVDF membrane. The membrane was stained with Coomassie Blue (A). 
Lanes 1, 2, 3 show the molecular mass markers (10 |ag), native PLD2 (5 p-g), and PLD2 
(5 (ig) treated with thermolysin for 240 min, respectively. PLD2 and fragments were also 
subjected to non-denaturing electrophoresis and blotted onto nitrocellulose membrane for 
activity staining (B). Lanes 1 and 2 show native PLD2 (10 pg), and PLD2 (10 |ig) treated 
with thermolysin for 60 min, respectively. 
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Table 6. N-terminal sequences of the fragments of PLD2 and L324S-PLD2 
obtained by proteolysis with thermolysin. 
Enzyme 
PLD2 
L324S-PLD2 
Band 
Band I 
Band II 
Band III 
Band I 
Band II 
Band III 
N-terminal sequence determined 
by protein sequencing 
Ile-GIy-Phe-Gly-Lys-GIy-Glu 
Leu-Gln-Val-Ser-AIa-Met-Phe 
Leu-Gln-Val-Ser-Ala-Met-Phe 
Ile-Gly-Phe-Gly-Lys-Gly-Glu 
Leu-Met-Ala-Thr-His-Asp-Glu 
Ile-Val-Gln-Asn-Ser-Gln-Val 
PLD2 sequence 
Assigned 
42-48 
324-330 
324-330 
42-48 
288-294 
320-326 
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Fig. 29. Proteolysis of PLD2 by thermolysin at ZS^ C after preincubation at various 
temperatures. PLD2 was exposed to 30°C, 40°C, or 50°C for 30 min, cooled and 
incubated with thermolysin at IS^C for 1 h. Lane 1 contain the molecular weight markers 
(10 (ig); lane 2, PLD2 (10 |ig) not exposed to thermolysin; Lanes 3-5 contain PLD2 
(10 |ig) preincubated at 30°C, 40°C, and 50°C, respectively prior to pretreatment with 
thermolysin. The mass ratio of PLD2 to thermolysin was 40:1. 
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Fig. 30. Proteolysis of PLD2 by thermolysin at IS^C in absence and in the presence 
of 20 niM CaCli. PLD2 was incubated with thermolysin at a mass ratio 40:1 in absence 
(lanes 2-7) or presence of 20 mM CaCl2 (8-13). Lanes 1 and 14 contain molecular weight 
marker proteins (5 )ig), while lanes 2 and 8 contain PLD2 (5 }j,g) not exposed to 
thermolysin. Samples in the lane 8 however also contained 20 mM CaCb. Lanes 3-7 
contain PLD2 (5 (ig) samples exposed to thermolysin for 1, 5, 30, 60, 240 min, 
respectively. Lanes 9-13 contain PLD2 (5 |ig) samples exposed in the presence of 20 mM 
CaCb to thermolysin for 1, 5, 30, 60, 240 min, respectively. 
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Proteolysis of PLD2 by themiolysin was also studied in the presence of the substrate 
1,2-PC and its structural analog 1,3-PC, which acts as competitive inhibitor of the 
enzyme (Haftendorn et al, 2000). These compounds were applied in form of mixed 
liposomes with SDS (Dittrich et al, 1998). In the absence of calcium ions, 1,2-PC as well 
as 1,3-PC protected the enzyme against proteolysis by thermolysin as demonstrated in fig. 
31. The protective function seems stronger with 1,2-PC, which when included in the 
reaction mixture delayed the formation of bands II and III till 1 h at 25°C. 
The protective effect of 1,2-PC however disappeared when the proteolysis of PLD2 
was performed in the presence of 20 mM CaCl2 (fig. 31). Infact the observed rapid 
proteolysis in the presence CaCb was further accelerated by the addition of 1,2-PC but it 
was decelerated by the addition of 1,3-PC. Under the conditions, 1,2-PC is however 
expected to be quickly converted into phosphatidic acid, whereas in the absence of 
calcium ions PLD2 is much less active (Schaffner et al, 2002). 
4.4.6. Proteolytic susceptibility ofPLDl mutants 
The putative first and second cleavage sites of PLD2 by thermolysin (Thr4I-Ile42 and 
Asn323-Leu324) as determined by fragment analysis (section 4.4.3) reveal a C-terminal 
He or Leu residue and a peptide bond in which the carboxyl group is contributed by He or 
Leu is preferentially cleaved by thermolysin (Bankus & Bond, 2001). To probe the 
influence of these specific residues in the vulnerability of PLD2, two enzyme mutants 
(I42S-PLD2 and L324S-PLD2) in which the He or Leu residue was substituted by a Ser 
residue were produced by site-directed mutagenesis. 
I42S-PLD2 was purified in three steps - octyl-Sepharose column chromatography, 
followed by MonoQ HPLC, and chromatography on the octyl-Sepharose column. 
However, the crude preparation containing I42S-PLD2 showed very low activity and was 
rapidly degraded during purification on octyl-Sepharose column (fig. 32A) and MonoQ 
HPLC (fig. 32B). The fractions that were relatively pure after rechromatography on the 
octyl-Sepharose column (fig. 32C) aggregated almost completely. 
In contrast, L324S-PLD2 was more stable and could be obtained in homogeneous 
form. It was similar to PLD2 in its electrophoretic behaviour and expressed 28 % activity 
towards hydrolysis of PpNP as compared to PLD2. The pattern of proteolysis of L324S-
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Fig. 31. Effect of 1,2-PC and 1,3-PC on proteolysis of PLD2 by thermolysin in the 
presence and absence of CaCh. Lanes 1 and 10 contain molecular mass markers 
(10 (ig). Lane 2 contain PLD2 (5 |ag), lane 3 PLD2 (5 \xg) subjected to proteolysis by 
thermolysin for 60 min. PLD2 (5 [ig) samples exposed to thermolysin for 60 min in 
presence of 1,2-PC and 1,3-PC were loaded in lanes 4 and 5, respectively. Lane 6 
contained PLD2 (5 (ig) incubated with 20 mM CaCl2 alone and lane 7 PLD2 (5 ^g) 
incubated with thermolysin + 20 mM CaCb for 60 min. PLD2 treated with thermolysin 
for 60 min in presence of 1,2-PC (lane 8) and 1,3-PC (lane 9) + 20 mM CaCb were also 
included. The mass ratio of PLD2 to thermolysin was 20:1. 
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Fig. 32. Purification of I42S-PLD2 expressed in E. coli BL21 (DE3) cells. (A) The 
lysate of E. coli (13 ml) was dialyzed against 30 niM PIPES, pH 6.2 containing 50 niM 
CaCl2 and loaded on the octyl-Sepharose column and elated as described in the methods, 
section 3.4.1. Fractions of 5 mi were collected and subjected to SDS-PAGE. Lanes 1-7, 
eluted fractions 12-18 (20 jul); lane 8, molecular mass markers (1 jig). (B) The fractions 
12-15 from (A) were pooled, dialyzed against 20 mM Tris/HCl buffer, pH 7.5 and loaded 
on the MonoQ column and eluted as described in the methods section, 3.4.1. Fractions of 
5 ml were collected and subjected to SDS-PAGE. Lane 1, molecular mass markers 
(1 |ig); lanes 2-8, eluted fractions 40-46 (20 |il). (C) The fractions 43 and 46 from (B) 
were pooled, dialyzed against 30 mM PIPES buffer, pH 6.2 + 50 niM CaCb and loaded 
on the octyl-Sepharose column and eluted as described in the methods section, 3.4.1. 
Fractions of 5 ml were collected and subjected to SDS-PAGE. Lane 1, molecular mass 
markers (1 |xg); lanes 2-8, eluted fractions 31-37 (20 \i\). 
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PLD2 by thermolysin was comparable with that of PLD2 (fig. 33A). N-terminal 
sequencing of the bands I, II and III of L324S-PLD2 (fig. 33B) revealed peptide 
fragments resulting from proteolysis starting with the amino acids 42, 288 and 320 of 
PLD2 (table 6). Therefore, the first, second, and third cleavage sites of L324S-PLD2 
were suggested to be Thr41-Ile42, Gly287-Leu288, and Ser319-Ile320, respectively. This 
implies that the first cleavage site of PLD2 is not affected by the mutation, whereas it 
results in a shifting of the second cleavage site to the next neighbouring bonds bearing 
Leu or He. Attempts to eliminate also these cleavage sites by creating the mutants L288S-
PLD2 and L288S/L324S-PLD2 led to inactive preparations indicating the role of the 
region in maintaining the catalytic activity of the enzyme. 
4.5. Studies on immobilized PLD2 
4.5.1. AntiPLDl antibodies 
The cross-reacfivity of anfiPLD2 antibodies with PLD2 was evident from the Western 
blotting experiment (fig. 34). The antiPLD2 IgG purified from the immune serum on a 
Protein A-Sepharose column (fig. 35) migrated in SDS-PAGE as two bands 
corresponding to the heavy chain (50 kd) and light chain (25 kd) of the IgG molecule (fig. 
35 Inset). 
4.5.2. Immobilization ofPLDl 
PLD2 was covalently bound on CNBr-activated Sepharose (PLD2-Sepharose). The 
theoretical and actual activity of PLD2 bound on the matrix is shown in table 7. The T] 
value was only 0.102, suggesting that Sepharose bound PLD2 expressed quite low 
activity. AntiPLD2 IgG when coupled to CNBr activated Sepharose was effective in 
binding PLD2 (PLD2-antiPLD2 IgG-Sepharose) (table 7) and the preparation exhibited a 
r| value of 0.383. As compared to the covalentiy bound preparation, PLD2 immobilized 
on the antibody support was more active on the substrate. It was however not possible to 
immobilize the enzyme on the support from crude extract. 
Fig. 33. Proteolysis of L324S-PLD2 by thermolysin at 25°C. Purified L324S-PLD2 
was exposed to themiolysin for various durations and the samples subjected to SDS-
PAGE. Lanes 1, 2, 3, 4, and 5 show the proteolysis of L324S-PLD2 (5 |ig) by 
thermolysin for 0, 5, 30, 60, 240 min, respectively. 
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Fig. 34. Western blot showing the cross-reactivity of antiPLD2 antibodies with 
PLD2. PLD2 (5 \xg) from SDS-PAGE gel was blotted onto nitrocellulose membrane. The 
membrane was blocked for 1 h with 4 % (w/v) skimmed milk in PBS and incubated with 
antiPLD2 antibodies (1:200 in PBS) for 2 h. After washing with PBS + 0.05 % Tween, it 
was blocked again with 2 % skimmed milk for 20 min and then incubated with antirabbit-
HRP conjugate (1:5000 in PBS) + 2 % skimmed milk for 80 min. The membrane was 
washed with PBS + 0.05 % Tween and detection done by chemiluminiscence [ECL-kit 
(amersham pharmacia biotech)]. Lane 1, prestained low range molecular mass markers 
(Bio-RAD); lane 2, PLD2. 
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Fig. 35. Purification of antiPLDl IgG on Protein A-Sepharose column. AntiPLD2 
immune serum was passed through a Protein A-Sepharose column and eluted with 0.1 M 
glycine/HCl buffer, pH 3.0 and fractions were analyzed for protein. The inset shows the 
SDS-PAGE of the purified IgG; lane 1, molecular mass markers (10 j^g); lane 2, pooled 
fractions 2-7 (20 )ig of protein was applied). 
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Table?. Immobilization of PLD2 on CNBr activated, and antiPLDZ IgG-
Sepharose supports. 
,^ PLD2 bound (munits) Effectiveness factor r\ 
PP° Theoretical (a) Actual (b) (b/a) 
CNBr activated Sepharose(lg) 1438.5 144.0 0.100 
AntiPLD2 IgG-Sepharose 1774.5 679.4 0.383 
(7.5 mg/g) 
Each value represents the mean of three independent determinations. Maximum variations 
did not exceed ± 2.0 munits. 
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4.5.3. Stability of soluble and immobilized PLD2 at 5(fC. 
Fig. 36 shows the inactivation of soluble PLD2, PLD2-Sepharose and PLD2-antiPLD2 
IgG-Sepharose at 50°C at various time intervals. Activity retained by soluble PLD2 was 
51 and 7 % after incubation at 50°C for 30 and 120 min, respectively, whereas, under the 
conditions PLD2-Sepharose retained 45 and 15 % of initial activity. However, the activity 
retained by PLD2-antiPLD2 IgG-Sepharose was markedly lower and it retained only 
11 % activity after 30 min incubation at 50°C and lost complete activity after 120 min. 
This suggests that while inactivation at 50°C of soluble PLD2 and PLD2 bound 
covalently to Sepharose was comparable, PLD2 bound to the antiPLD2 IgG was far more 
labile. 
4.5.4. Effect of temperature on the activity of soluble and immobilized PLD2 
The temperature optimum both of soluble PLD2 and PLD2-antiPLD2 IgG-Sepharose 
was 50°C (fig. 37). PLD2 bound on antiPLD2 IgG support however exhibited 
comparatively lower activity at each temperature than soluble PLD2. PLD2-Sepharose 
exhibited comparable activity at 40 and 50°C but higher activity in the lower temperature 
range (below 50°C) than the other preparations. 
4.5.5. Storage stability of soluble and immobilized PLD 2 
The activity retained by soluble and immobilized PLD2 preparations stored at 6-8°C is 
shown in fig. 38. Activity retained by soluble PLD2 was 80 % of initial activity after day 
1 but the decrease in activity was slow subsequently and the preparation retained 67 % 
activity after day 6. The PLD2-Sepharose showed superior storage stability than soluble 
PLD2 and retained 95 % activity after day 1 and 83 % after day 6. The loss of activity in 
the case of PLD2-antiPLD2 IgG-Sepharose was however very rapid with the preparation 
retaining 77 % activity after day 1 and 13 % after day 6. 
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Fig. 36. Stability of soluble and immobilized PLD2. Soluble PLD2 (•) and that bound 
covalently to Sepharose (•) or noncovalently to antiPLD2 IgG-Sepharose (O) were 
exposed to 50OC for various durations and residual activity determined. Details are given 
under methods section, 3.5.4. 
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Fig. 37. Effect of temperature on the activity of soluble and immobilized PLD2. 
Activity of soluble PLD2 (•) and that bound covalently to Sepharose (•) and 
noncovalently to antiPLD2 IgG-Sepharose (0) were determined as a function of 
temperature. Details are given under methods section, 3.5.5. 
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Fig. 38. Storage stability of soluble and immobilized PLD2. Soluble PLD2 (•) and 
that bound covalently to Sepharose (•) and noncovalently to antiPLD2 IgG-Sepharose 
(O) were stored at 6-8^0 for various days and residual activity determined. Details are 
given under methods section, 3.5.6. 
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5. DISCUSSION 
5.1. Studies on RNase A 
Binding to antibody supports lias been siiown to markedly improve the stability of 
several enzymes against inactivation (Saleemuddin, 1999). Both monoclonal and 
polyclonal antibodies have been successfully employed in the immobilization of 
enzymes. Table 2 lists the impressive enhancement in the stabilities of the 
in7munoaffirjity immobilized enzymes against high temperature, chemical denaturants, 
proteolysis, oxidative stress, etc. Studies using antibodies which bind to enzyme antigens 
at distinct and well-defined site(s), have led to a better understanding of the effects of 
enzyme-antibody interactions on enzyme behaviour (Solomon et al., 1996). By 
appropriate selection it has been possible to isolate those antibodies that are non-
inhibitory and bind at strategic locations on the antigen molecule, leading to considerable 
stabilization of the enzyme conformation (Turkova, 1999, Jafri & Saleemuddin, 1997, 
Solomon et al, 1987). Solomon et al. (1987) have shown that among the spectrum of 
antienzyme monoclonal antibodies, those imparting high activity can be screened. 
After the proposal of the existance of labile region in enzyme molecules where 
unfolding begins (Ulbrich-Hofmann et al, 1993), such regions have been identified in 
several enzymes (Arnold et al, 1996; Arnold et al, 1998; Engen et al, 1997; Eijsink et 
al, 1995). Since modification of labile region has been shown to alter the stability of the 
enzyme, the possibility of using antibodies directed against labile region of enzyme for 
improving the stability was envisaged. 
Both the RNase A and the dodecapeptide corresponding to the labile region of the 
RNase A (Arnold et al, 1996) were immunogenic and readily elicited the formation of 
antibodies in rabbits. The binding of RNase A to the antiLpep antibodies, however, 
appeared relatively lower (fig. 12B), presumably due to the limited exposure of the labile 
region of RNase A to the surface at moderate temperatures (Arnold et al, 1996). Sarger 
et al (1989) have reported poor immunogenicity of the peptide corresponding to the 
region 37-43 which was also shown in an earlier X-ray crystallography study to have 
limited surface access (Kartha et al, 1967). The presence of four additional hydrophilic 
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amino acid residues on the N-terminal side of the dodecapeptide apparently contributes to 
the immunogenicity and antigenicity of the peptide observed in this study. The cross-
reactivity of the antiRNase antibodies with the Lpep was demonstrated by allowing these 
antibodies to interact with RNase A in the presence of the peptide (fig. 13). The results 
clearly imply the competition of Lpep with whole RNase A for binding with certain 
population of antibodies. However, the magnitude of the decrease in absorbance suggests 
that only a small fraction of antibodies recognize the labile region of the enzyme. 
The r| values of RNase A bound to antiRNase IgG and antiLpep IgG supports were 
0.93 and 0.57, respectively (table 3). RNase A immobilized by conventional procedures 
usually exhibits low activities (Axen et al, 1971; Koch-Schmidt & Mosbach, 1977; 
Messing, 1970) and the high T] values expressed by the antibody support-immobilized 
enzyme are therefore remarkable. RNase A covalently immobilized on CNBr activated 
Sepharose has also been shown to exhibit improved stability albeit the expense of 
substantial loss of catalytic activity (Koch-Schmidt & Mosbach, 1977). An increase in the 
number of covalent linkages between RNase A and the support from one to eight resulted 
in a decrease in specific activity towards cyclic cytidine 2', 3'-monophosphate as substrate 
from 60 % to 15 % and an increase in transition temperature by 4.5°C (Koch-Schmidt & 
Mosbach, 1977). High expression of catalytic activity, however, has been observed in 
case of several other enzymes bound on antibody supports (Saleemuddin, 1999; Solomon 
et al, 1987; Stovickova et al, 1991). This has been ascribed primarily to the antibody 
molecule acting as an effective spacer and minimizing steric hindrance in the approach of 
the substrate (Solomon et al, 1986). The low r) values of the RNase A immobilized on 
antiLpep support as compared to that immobilized on antiRNase antibody may be related 
to the binding of the enzyme to the matrix via a region located in the vicinity of the active 
site. Lysine 41 has been shown to be important for the catalytic activity of RNase A 
(Raines, 1998). However, as mentioned earlier, the regions towards the N-terminus of the 
Lpep may actually be antigenic, which may explain the observed lack of inhibition of 
antiLpep antibodies. While the specificities of antiRNase IgG have not been ascertained, 
those recognizing the labile region seem to comprise only a small fraction of the total 
population. It is, however, not unlikely that RNase A may be preferentially bound on the 
antiRNase IgG support only through one or few epitope(s) exhibiting high affinity for the 
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immobilized IgG. High expression of activity by the immobilized RNase A, however, 
suggests that binding may not occur via epitope(s) located in the proximity of the active 
site. Active sites of many enzymes act as blind spots for the immune system due to their 
localization in the crevices (Shami et al, 1989). 7"he enzyme coupled to CNBr activated 
support, however, exhibited low r| values (Koch-Schmidt & Mosbach, 1977) possibly due 
to the coupling of a significant fraction of molecules through the crucial lysine residues. 
RNase A immobilized on Sepharose support precoupled either with the antiLpep IgG 
or antiRNase IgG proved to be more resistant to thermal inactivation than the soluble 
enzyme (fig. 15). The fraction of activity retained was higher in case of RNase A 
immobilized on the antiRNase antibody supports. It is quite likely that because of the 
presence of antibodies recognizing several epitopes of the RNase A in the antiRNase IgG. 
the bound enzyme may interact with more than one antibody molecule. Such lateral 
interaction of enzymes with matrix bound antibody may contribute significantly towards 
the stability of the enzyme (Shami et al, 1989; Jafri et al, 1993). Several instances of 
enhancement of resistance of enzymes bound to antienzyme polyclonal/monoclonal 
antibodies are available in the literature (Solomon et al, 1987; Shami et al, 1991). The 
immobilized preparations also retained greater fraction of activity both in the acidic and 
alkaline range (fig. 16). The support bearing the antiLpep antibodies was superior in 
protecting the bound RNase A from inactivation both in the acidic and alkaline range than 
the support bearing antiRNase antibodies. 
The stability against inactivation by trypsin at 55°C was markedly high when RNase A 
was immobilized on the antiLpep IgG support, as compared to the soluble and other 
immobilized preparations (fig. 17A). The enhancement in the resistance of the 
immobilized preparations to trypsin induced inactivation was, however, of far lower 
magnitude at 60°C (fig. 17B). The observed enhancement in stability against thermal 
inactivation and trypsinization at high temperatures is apparently related to restriction in 
the unfolding of the RNase A due to the binding of labile region by the antibodies 
(Arnold et al, 1996) and/or steric hindrance in the approach of the protease (Jemmerson 
& Stigbrand, 1984). In view of the unusually high thermal stability of the native RNase A 
it is difficult to distinguish if the observed enlianced retention of activity at elevated 
temperature is related to the restriction of unfolding or due to the masking of the 
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unfolding region. The apparent decrease in protection at 60°C may be related to the 
inability of the antibodies to prevent the conformational alterations in the labile region at 
such temperatures, due to an alteration in the affinity of the enzyme. 
An alternative approach of introducing a cysteine residue in the labile region of a 
thermolysin like protease by site-directed mutagenesis and subsequent immobilization on 
support via the sulphhydryl was highly successful in improving the thermal stability of 
the enzyme (Mansfeld et al, 1999). In a latter study, the effective immobilization of a 
recombinant RNase A bearing an engineered sulphhydryl (delCardayre & Raines, 1994) 
on sulpholink resin has been described (Sweeney et al, 2000). The interesting strategy, 
however, is limited to the enzymes that lack free cysteines in their structure. 
A protease resistant, readily recoverable RNase A preparation, such as the one 
described in this study, exhibiting high activity on RNA may find several applications 
including those in the production of pure DNA preparations and other products lacking 
RNA. Furthermore, the strategy of using antibodies raised against the labile regions of 
enzymes maybe useful in increasing their stability against specific forms of inactivation, 
such as high temperature, pH, proteolysis, etc. 
It has been shown using RNase A as a model, that antibodies raised against the 
peptides corresponding to the labile region of enzyme can be used to prepare affinity 
supports that bind and selectively confer enhanced stability against thermal, pH and 
protease induced inactivation to the enzyme. 
5.2. Studies on L35S-RNase A 
Site-directed mutagenesis has facilitated detailed analysis of stabilizing interactions in 
various proteins (Fagain, 1995). A mutant RNase A that has a single amino acid exchange 
in the labile region (Leu35—>Ser) was produced to study the effect of such substitution in 
the crifical region (fig. 18). Although the mutation is not located in close proximity of the 
active site, enzyme activity of L35S-RNase A was only 43 % as compared to the 
pancreatic RNase A (table 4). Conformational perturbations resulting from the 
replacement of a hydrophobic leucine residue with the hydrophilic serine apparently 
account for the decrease. The replacement of a single amino acid residue in the unfolding 
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•region of RNase A also resulted in a marked decrease in stability against heat (ATm=9°C) 
(table 4). While the introduction of a proline residue into the loop region around the 
position 20 did not affect the conformational stability of RNase A (Markert et al. 2001), 
substitution of Ser35 for Leu altered the stability remarkably (fig. 19, fig. 20). Binding of 
antibodies recognizing the labile region markedly improves the stability of the mutant 
RNase A (fig. 22). The remarkable protection offered by the antiLpep anfibody support is 
evidently related to its ability to restrict unfolding by binding L35S-RNase A via the 
labile region. Apparently polyclonal antibodies raised against RNase A also contain 
populations of those that recognize the labile region of the enzyme. This may account for 
the observed lower stability of the preparation immobilized on the antiRNase antibody 
support pretreated with the labile region peptide. 
Prevention of aggregation is one of the advantages of immobilization of enzymes on 
solid supports. Since the inactivation of soluble L35S-RNase A after 1 h at 65°C was 
much larger (80 %) than the observed increase of aggregation (15 %) (fig. 21), prevention 
of aggregation may not be the major contributor towards the observed stability of L35S-
RNase A on the antibody supports. 
The results demonstrate the role of the labile region of RNase A in the thermal 
stability of the RNase A. The work also demonstrates potential of the strategy of 
stabilizing enzymes via antibodies directed against labile structural regions. Considering 
that evidence regarding the existence of labile regions in several enzymes is 
accumulafing, labile region specific antibodies may emerge as useful tools in the specific 
stabilization of enzymes against inactivation. In addition, the antienzyme antibodies 
coupled to suitable supports may help in direct and favourably oriented immobilization of 
enzymes even from crude lysates. 
5.3. Studies on RNase A aggregation 
RNase A has been shown to aggregate at 65°C gradually and only to a small extent. 
Also when concentrated in mildly acidic solutions, RNase A forms oligomers (Liu et al, 
2002). The major dimeric component forms by swapping of the C-terminal P-Strand 
between the monomers, and the minor dimeric component forms by swapping the N-
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temiinal a-helices of the monomers. The possibihty of RNase A sticking to the walls of 
the eppendorf rather than aggregating at 65°C has been ruled out (fig. 24A). AntiRNase 
antibodies and to a lesser extent antiNpep antibodies were effective in reducing RNase A 
aggregation at 65°C (fig. 24B). Apparently the antiNpep antibodies prevent RNase A 
aggregation by binding to the N-terminal part of the enzyme, and create steric hindrance 
in the swapping of the N-terminal a-helices of the monomers. The antiRNase antibodies 
were more effective in protecting RNase A against aggregation, in view of their 
likelihood of recognizing several epitopes of the enzyme and hence create steric 
hindrance in the approach of the monomers from all directions. 
These results suggest the usefulness of antibodies, directed against specific epitopes of 
the enzymes involved in initiation of aggregation, in preventing the enzyme aggregation. 
It also suggests that the polyclonal antienzyme antibodies may also be highly effective in 
preventing aggregation, but useful only if they are non-inhibitory, as in the present 
situation. 
5.4. Studies on the Proteolysis of PLD2 
Most proteins are resistant to limited proteolysis in their native globular 
conformations. Proteolytic cleavage of native proteins principally occurs only at the 
surface of the molecule and necessitates high flexibility of loop regions or other flexible 
segments (Fontana, 1999). Limited proteolysis is therefore an appropriate tool in 
identifying sites of flexibility along the polypeptide chain and in locating structural 
domains (Fontana, 1999). In the interpretation of conformational studies by proteolysis, 
the specificity of the applied proteases has to be considered as one of the most important 
limitations of the approach (Price & Johnson, 1990). Non-specific proteases have the 
advantage that the protein conformation is likely to be more important for the first 
cleavage than the amino acid sequence. Loose and therefore susceptible regions (loops) 
of proteins should be better detectable using non-specific than by residue-specific 
proteases. 
The present study reveals that, PLD2 is unusually susceptible towards proteases, 
suggesting the presence of highly flexible structural regions. With the proteases 
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chymotrypsin and trypsin, which are specific to the bond cleavage at the C-temiinal side 
of aromatic (Phe, Tyr, Trp) and basic amino acids (Lys, Arg), respectively, proteolysis 
even at 25°C was too rapid to be followed by accumulation of larger fragments (fig. 26). 
Cleavage with thermolysin however lead to the accumulation of three larger fragments as 
revealed by SDS-PAGE (fig. 27 and the left part of fig. 32 [lanes 2-7]). Their analysis by 
MALDl-TOF mass spectrometry (table 5) and N-terminal protein sequencing (table 6) 
allows the conclusion that the N-terminal region of PLD2 is highly flexible and sensitive 
to proteolysis. The first cleavage site is suggested to be Thr-41-Ile42. This bond is located 
within the C2 domain of PLD2, which covers a.a. 8-153 (fig. 39). C2 domains consist of 
eight P-strands which are connected by exposed loop regions (Nalefski & Falke, 1996). 
Thr41-Ile42 in PLD2 should be positioned in an exposed loop between the strands P2 and 
P3. This is the most exposed loop in the C2 domain of synaptotagmin I, the crystal 
structure of which has been elucidated (Sutton et ah, 1995). According to the results of 
activity assays including activity staining in PAGE (fig. 28B), this cleavage causes the 
complete loss of activity. 
A second cleavage site could be identified at the position Asn323-Leu324, which is 
located close to the N-terminal side of the first HKD motif (fig. 39). The resulting C-
terminal fragment (peptide II, a.a. 324-812) and its C-terminally truncated derivative 
(peptide III, a.a. 324-798) proved to be relatively stable. Mutation of Leu324 shifted the 
second cleavage site to Gly287-Leu288 and Ser3I9-Ile320 (fig. 39), showing that a 
flexible region may be located before the first HKD motif and may comprise of more 
than 35 amino acid residues. Although the third cleavage site Ile798-Leu799 converting 
peptide II into peptide III also indicates a certain degree of flexibility of the C-terminus of 
PLD2, the results suggest that the C-terminal part of PLD2 comprising the two HKD 
motifs (a.a. 333-348 and a.a. 663-680) form a more compact structure than the N-terminal 
part. Obviously the N-terminal part is important for the dynamics of the molecule and 
intum for the activity. This argument would also explain the high sensitivity of PLD2 
toward mutations, which were introduced at the cleavage sites. Only L324S-PLD2 
retained reasonable activity (28 % of the wild-type activity), whereas L288S and 
L288S/L324S were catalytically completely inactive. I42S-PLD2 showed low activity in 
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41-42 
(8-153) 
287-288 319-320 323-334 798-7» 
"nr^ 's^m irs^soc 
GILHA.II UjyFKVE 
FirstHKD motif 
(333-348) 
HqcrVWDSEVPSQGG 
S«condHKD motif 
(663-680) 
HsonnvDDEvnvGSWJ 
Fig. 39. Scheme of the primary structure of PLD2 with cleavage sites of 
thermolysin. Full arrows mark cleavage sites in PLD2. Dotted arrows mark 
cleavages sites in L324S-PLD2 instead of that at Asn323-Leu324. 
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the crude cell extract but was degraded and aggregated during purification, hence was 
very unstable. 
The strong acceleration of proteolysis after a pre-incubation at 40 and 50°C (fig. 29) 
indicates that PLD2 is irreversibly unfolded at the temperatures and proteolysis of the 
partly unfolded enzyme is even faster. 
The most striking result however is the acceleration of proteolysis by Ca^^ ions (fig. 
30). A similar destabilizing effect of Ca ^ ions was also observed on the storage stability 
of PLD2 (S. Haufe & R. Ulbrich-Hofmann, unpublished results). The data suggests that 
this effect may be connected with the conformational changes in the N-terminal part of 
PLD2, which promote proteolytic accessibility. The observed protective effects of the 
substrate 1,2-PC and the substrate analog 1,3-PC indicate their role in the modification of 
the conformation of the enzyme (fig. 31). The protective effect of 1,2-PC unlike that of 
1,3-PC however disappeared in presence of Ca "^ . Acfivity of PLD2 is very low in the 
absence of Ca^^ ions, hence the protective effect of the two regioisomers are comparable. 
In presence of Ca'^ ,^ ions 1,2-PC is expected to be rapidly converted into phosphatidic 
acid but 1,3-PC is not acted upon by the enzyme. Hence, it may be possible that a 
degradation products of 1,2-PC may perhaps further accelerate the proteolysis. Since the 
C2 domain, which contains the first cleavage site for thermolysin, is known to be 
involved in calcium mediated membrane binding of several proteins (Nalefski & Falke, 
1996), this region is assumed to be responsible for the observed effects. The results also 
support the hypothesis of Zheng et al. (2000) who studied conformational changes of the 
isolated C2 domains of PLDa and PLDp from Arabidopsis induced by Ca^^ ions and 
concluded that Ca^^ binding to a PLD C2 domain perturbs the secondary structure of the 
protein and exposes a hydrophobic surface that binds to neutral phospholipids. 
5.5. Studies on immobilized PLD2 
PLD2 immobilized covalently on CNBr-activated Sepharose expressed only 10 % 
activity of the wild type enzyme (table 7). The observed low activities of immobilized 
enzymes may result from partial denaturation, changes of enzyme kinetics, partition 
effects, and mass transport limitations, etc (Ulbrich, 1989). For immobilized PLD2, in 
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any case, mass transport limitations have to be taken into consideration as a possible 
reason for activity losses, because the substrate used is in emulsified fomi and will be, 
despite intensive stirring, less accessible to the immobilized enzyme than to the soluble 
enzyme although other factors may also play a role. PLD2 immobilized non-covalently 
onto antiPLD2 IgG-Sepharose expressed comparatively higher activity (38 %) (table 7). 
This is due to the fact that, the antibody molecule acts as a large spacer holding the 
enzyme at a distance from the support matrix thereby minimizing steric hindrance and 
facilitating freedom to act even on miceller substrates. 
The inactivation at 50°C for soluble PLD2 and PLD2-Sepharose was comparable, 
while that of PLD2-antiPLD2 IgG was very fast (fig. 36). Thus while resistance to heat 
induced inactivation was unaffected on its coupling to CNBr activated Sepharose, binding 
to the antibody support made the enzyme labile. The activity exhibited by PLD2-
antiPLD2 IgG-Sepharose was also significantly lower at each temperature as compared to 
the soluble enzyme although the temperature optimum was the same (50°C) (fig. 37). 
However, PLD2-Sepharose exhibited a broader temperature optimum (40-50°C) and 
higher activity at temperatures below 50°C. The storage stability at 6-8°C of PLD2-
Sepharose was also higher than the soluble enzyme (fig. 38) but that of PLD2-antiPLD2 
IgG-Sepharose was dramatically lower. 
Although enzymes immobilized on antibodies usually exhibit high operational and 
storage stability, binding to antiPLD2 antibodies rendered the enzyme labile. It may be 
possible that the antiPLD2 IgG comprise of populations of antibodies that bind to 
epitopes of the enzymes that are important for the stability. The antiPLD2 antibodies used 
also appear to be of low affinity, smce antiPLD2 IgG-Sepharose binds purified PLD2 but 
were ineffective in binding the enzyme for crude lysates. 
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Stabilization of pancreatic ribonuclease A by immobilization on 
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the labile region of the enzyme 
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Abstract 
The stabilizing potential of the antibodies recognizing the labile region of pancreatic ribonuclease A (RNase) has been 
investigated. The dodecapeptide SRNLTKDRAKPV corresponding to the labile region 32-43 on RNase was synthesized by 
the solid-phase method. Antiserum raised against the dodecapeptide-bovine serum albumin conjugate showed good cross-
reactivity with the peptide and native RNase. RNase immobilized on Sepharose support precoupled either with the 
antipeptide immunoglobulin (IgG) or anti-RNase IgG proved to be more resistant to thermal inactivation than the soluble 
enzyme. Besides, stability against inactivation by trypsin at 55°C was markedly high when enzyme was immobilized on the 
antipeptide IgG support, as compared to the soluble and other immobilized preparations. These results suggest that matrices 
bearing antibodies recognizing specific labile regions of enzyme may be useful in selectively improving their stability against 
specific forms of inactivation. © 2001 Elsevier Science B.V. All rights reserved. 
Keywords: Ribonuclease A; Antibody; Affinity immobilization; Unfolding nucleus; Enzyme stabilization 
1. Introduction 
It is now well recognized that the resistance of a 
number of enzymes to various forms of inactivation 
can be increased by their immobihzation on soUd 
supports. Several studies suggest that the nature 
and number of linkages through which an enzyme 
Abbreviations: RNase, pancreatic ribonuclease A; BSA, bo-
\ine serum albumin; ELISA, enzyme-linked immunosorbent as-
say 
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is attached to the support determine its performance 
and stability in the immobilized state [1,2]. The use-
fulness of orienting enzymes favourably on support 
matrices is also being increasingly realized [3]. 
Among the various strategies available for favour-
able orientation of enzymes [4], the use of monoclo-
nal antienzyme antibodies is particularly promising 
[5,6]. While polyclonal antibodies have the inherent 
disadvantage of heterogeneity, interesting strategies 
for improving their selectivity towards specific re-
gions of enzymes are available. These include those 
that prevent the formation of active site directed 
antibodies [3.7] and help in generation of antibodies 
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Abstract 
The region between the amino acids 31-46 was previously identified as being first exposed during thermal unfolding 
of bovine pancreatic ribonuclease A (RNase). The exchange of one amino acid (Leu35->Ser) in this unfolded 
region of RNase is shown to have a dramatic destabilizing effect (ATm = 9 °C). Antibodies raised against a 
peptide corresponding to the sequence of the labile region, S32-V43, of RNase were effective in stabilizing L35S-
RNase against thermal inactivation (65 °C for 2 h) and surpassed the stabilization effect of antiRNase antibodies. 
An 11% contribution to the stabilizing effect of antiRNase antibodies resulted from antibodies recognizing the 
unfolding region of the enzyme. 
Introduction 
Thermal inactivation is a serious limitation in vari-
ous enzyme applications and numerous strategies are 
available to improve the stability of enzymes against 
high temperatures. Among these, the orientation of en-
zymes on support matrices has proved to be highly ef-
fective (Turkova 1999). Binding to antibody supports 
has also been shown to markedly improve the stability 
of several enzymes against inactivation (Saleemud-
din 1999). Both monoclonal and polyclonal antibodies 
have been successfully employed in the immobiliza-
tion of enzymes. Studies using antibodies which bind 
to enzyme antigens at distinct and well-defined site(s), 
have led to a better understanding of the effects of 
enzyme-antibody interactions on enzyme behaviour 
(Solomon et al. 1996). By appropriate selection it 
has been possible to isolate those antibodies that are 
non-inhibitop.' and bind at strategic locations on the 
antigen molecule, leading to considerable stabilization 
of the enzyme conformation (Turkova 1999. Jafri & 
Saleemuddin 1997. Solomon era/. 1987), 
In vitro stability of protein reflects the molecu-
lar integrity of the constituent polypeptide chain(s). 
In recent years, understanding both of the inactiva-
tion processes and of the stabilizing interactions has 
increased. Site-directed mutagenesis has facilitated 
detailed analysis of stabilizing interactions in proteins 
(Fagain 1995). In ribonuclease A (RNase) (see Fig-
ure 1), the region between the amino acids 31-46 
was identified as being the first to be exposed dur-
ing thermal unfolding of the enzyme (Arnold et al. 
1996). Antibodies recognizing this labile region (S32-
V43) can then stabilize RNase against thermal and 
trypsin induced inactivation (Younus et al. 2001). In 
the present study we show that the exchange of a single 
amino acid in the labile region (L35S) (see Figure 1) 
leads to marked decrease of the thermal stability of 
RNase. The effect of binding of polyclonal antibodies 
raised against pure RNase or those directed against the 
labile region of the enzyme on the thermal stability of 
L35S-RNase has been investigated. 
